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Abstract
Pain is the most common reason people seek healthcare. Initiatives to prevent the undertreatment
of pain have resulted in overreliance on opioids to treat pain. Despite significant increases in
opioid use, pain is more prevalent than ever. Additionally, devastating consequences from opioid
use have resulted, such as dependence, addiction, and increasing opioid-related deaths. Research
demonstrates multimodal analgesic therapy is an effective alternative to the overreliance on
opioids to treat pain. Multimodal analgesia is the synergistic use of two or more analgesics with
different mechanisms of action. Multimodal analgesia produces significantly more effective and
efficient pain management than opioid-only therapy. This project will focus on implementing
multimodal analgesia pain management practices and determine its effect on opioid use on an
Observation unit.
Keywords: multimodal analgesia, pain management, opioid use
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Effect on Opioid Use following the Implementation of Evidence-Based Pain Management
Practices for an Observation Unit
Pain is the most common reason people in the United States (US) seek healthcare and is
the primary cause of disability in the US (National Institutes of Health, 2013). The International
Association for the Study of Pain (2012) defines pain as "An unpleasant sensory and emotional
experience associated with actual or potential tissue damage, or described in terms of such
damage". Pain is more prevalent than diabetes, heart disease, stroke, and cancer combined (The
National Center for Health Statistics, NCHS, 2006). The most common types of pain include low
back pain (28.1%), headache or migraines (16.1%), neck pain (15.1%) and knee pain (19.5%)
(Institute of Medicine, 2010). As a result, analgesics, such as opioids, are among the most
commonly prescribed class of therapeutic medications for both inpatient and outpatient settings
(NCHS, 2017).
A desire by clinicians to treat pain has led to the increase in opioid reliance. A large,
prospective multicenter study found that only 60% of people who presented to the emergency
department (ED) with pain received analgesics, and 3 of 4 of these individuals were discharged
in moderate to severe pain (Todd et al., 2007). In response, pain was deemed undertreated and
initiatives to increase clinician identification and treatment of pain were prompted. Initiatives
include the American Pain Society “Pain as the fifth vital sign” campaign, the Joint Commission
on Accreditation of Healthcare Organizations (JCAHO) pain management standards, and the
World Health Organization (WHO) pain ladder to educate providers and patients on the stepwise
approach for pharmacological treatment of pain. As a result, opioids were increasingly relied
upon. Between 2000 and 2010, patients treated for pain pharmacologically in the ED increased
from 56% to 71%, although patients treated exclusively with non-opioids decreased 21%, from
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28% to 22% (Chang, Daubresse, Kruszewski, & Alexander, 2014). Furthermore, opioid
prescriptions quadrupled, opioid use in EDs increased 60%, and opioid sales skyrocketed 400%
between 1999 and 2010 (Centers for Disease Control and Prevention [CDC], 2011; CDC, 2016;
Simon, 2012).
Despite efforts to combat undertreatment of pain with opioids, overreliance on opioids
proved ineffective and is leading to devastating consequences. There has been no change in selfreported pain prevalence since 1999, and the percentage of patients seeking care in the ED for
severe pain has increased from 25% to 40% between 2003 and 2008 (CDC, 2016; Chang et al.,
2014). Nearly 25% of individuals who have received long term opioid prescriptions struggle with
addition (Boscarino et al., 2010). In 2011, approximately 1.5 million people were treated in the
ED due to prescription drug misuse, nearly triple the amount from 2004 (Substance Abuse and
Mental Health Services Administration, SAMHSA, 2013). Additionally, there has been an
annual increase in opioid related deaths, a 300% increase in reported opioid abuse, and nearly
fourfold increase in substance abuse related admissions (SAMHSA, 2010).
Contributing to this opioid crisis is the weak evidence it is based upon. The WHO pain
ladder is frequently used as justification for prescribing opioids for persistent or severe pain
(Blondell et al., 2013; Teater, 2014). Unfortunately, the WHO pain ladder was developed by
expert opinion for cancer-related pain, and not built upon randomized controlled trials (VargasSchaffer, 2010). A letter to the editor of the New England Journal of Medicine further promoted
the misconception of the safety of opioids. Porter and Jick (1980) reviewed nearly 12,000
hospitalized patient records for evidence of opioid addiction after receiving at least one opioid.
The authors identified just 4 records with reasonable documentation of addiction; thus,
concluding that opioid addiction is rare (Porter & Jick, 1980).
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Efforts to decrease reliance on opioids have emerged. Guidelines that dissuade clinicians
from dependence on opioids are increasing. This includes a 2012 American College of
Emergency Physicians guideline recommending short-acting opioid prescriptions for
musculoskeletal pain, avoidance of opioids for chronic non-cancer pain, and reserving opioids
for the most severe back pain complaints (Cantrill et al., 2012). The American Society
Anesthesiologists Task Force on Acute Pain Management (2012) released a guideline
recommending multimodal techniques for pain management. Nevertheless, uptake of these
guidelines is either incomplete or ineffective, as 2015 was the deadliest year on record for
opioid-related deaths (CDC, 2017).
Scientists are beginning to challenge the opinion that opioids are the only effective
treatment for severe pain (Teeter, 2014). Instead, the approach to pain management should be
focused on alleviating the cause of the noxious stimuli. The primary mechanisms of pain
sensation are nociceptive and neuropathic (Woolf, 2004). Each causes pain through a unique
mechanism. Thus, each pain classification needs a different approach to reduce the painful
stimuli. Rarely, however, is pain caused by a single mechanism. Pain is most often multifactorial
– meaning the pain sensation is a product of more than one mechanism, and needs to be treated
accordingly (Xu & Yaksh, 2011).
In order to improve the treatment of pain, understanding the mechanisms that lead to the
interpretation of pain is necessary. Nociceptive pain occurs when nociceptors (nerves that
transmit pain signals) detect a noxious stimulus with potential to cause harm to the body
(Nicholson, 2006). Nociceptors transmit signals via the pain pathway from the peripheral
nervous system (PNS) to the central nervous system (CNS) where the signal is interpreted as
pain (Xu & Yaksh, 2011). The most common trigger of nociceptors is actual or potential tissue
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damage (Nicholson, 2006). Inflammation occurs as the body’s immune system responds to the
actual or potential tissue damage (Xu & Yaksh, 2011). Neuropathic pain occurs when there is
direct injury to the peripheral nerve, resulting in persistent pain sensation due to continuous
activation of the nerve (Xu & Yaksh, 2011). Neuropathic pain can be a consequence of direct
nerve injury, as in surgery or an injury, or indirectly through diabetic peripheral neuropathy,
post-herpetic neuralgia, and cancer (Nicholson, 2006).
Several analgesics disrupt the transmission of the pain signal at various levels of the pain
pathway. Opioids exert their analgesic effects by binding to opioid receptors on neuronal cell
membranes, thus, inhibiting the afferent nerve transmission responsible for communicating pain
(Busti, 2015). The primary effect of opioids on the nervous system produces analgesia, but
concomitant effects also occur. Side effects of opioids include dizziness, nausea, constipation,
respiratory depression, mood changes, physical dependence, tolerance, and a decrease in
emotional distress (Benyamin et al., 2008; Chahl, 1996).
Non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are non-opioid
analgesics that work differently than opioids to reduce pain. NSAIDs reduce pain by blocking
cyclooxygenases (COX-1 and COX-2) peripherally, enzymes responsible for the production of
prostaglandins, a chemical central to inflammation, fever, and pain (Ogbru, 2016). Less
inflammation equates to less noxious stimuli being perceived by nociceptors in the PNS. The
mechanism of action for Acetaminophen is less understood. The belief is that acetaminophen
blocks the COX-1 enzyme in the CNS, thereby reducing prostaglandins centrally and disrupting
the neurotransmission of the pain signal in the brain and spinal cord (McNicol, 2008). Side
effects of these non-opioids can be dangerous if taken long-term or in high doses; however,
physical dependence and tolerance to these drugs are unlikely (Gavura, 2013).
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An alternative to overreliance on opioids for treatment of pain is multimodal analgesia.
Multimodal analgesia is combining two or more agents with different mechanisms of action to
produce a synergistic effect on pain relief (Young & Buvanendran, 2012). A multimodal regimen
could be tailored to the individual, mechanisms causing the pain, side effects of the medication,
and the person’s preexisting medical and psychosocial conditions (Buvanendran & Kroin, 2009).
Multimodal analgesia has the potential to relieve pain at multiple levels of the pain pathway by
optimizing dosages of separate agents to produce maximum efficacy while minimizing sideeffects that can occur when relying on a high dose single analgesic (Young & Buvanendran,
2012).
This Doctor of Nursing Practice (DNP) project will focus on identifying literature
regarding efficacious pain management practices, such as multimodal analgesia, with the
potential of reducing reliance on opioids. The setting for this DNP project is an ED Observation
(OBS) unit in a freestanding midwestern hospital. An OBS unit is a clinical area of the ED where
cohorts of patients needing extended ED care are placed for continued observation (SalvadorKelly, Kwon, & Wheatley, 2016). The OBS unit is an ideal setting because many patients
present to the ED with pain and are cared for by the OBS unit. The providers and registered
nurses (RN) are accountable to their patients and must deliver effective pain management that
provides the most benefit while producing the least amount of harm.
Current Practices
The current practices of pain management on the OBS unit were assessed. The goal of
this analysis was to determine what extent the OBS unit relies on opioids to treat pain. To do
this, a report from the two Pyxis systems on the OBS unit was generated. This report contained
data on analgesics withdrawn over a 60-day period from May 5, 2017-July 4, 2017. Analgesics

IMPLEMENTION OF EVIDENCE-BASED PAIN MANAGEMENT

10

included were morphine, dilaudid, acetaminophen/hydrocodone (Norco), oxycodone,
acetaminophen/codeine (Tylenol #3), acetaminophen, and ibuprofen. Morphine, dilaudid, and
oxycodone are opioids. Norco and Tylenol #3 are multimodal analgesics as they contain both
opioid and non-opioid ingredients. Acetaminophen and ibuprofen are non-opioids. For this
analysis, it was assumed that if the medication was withdrawn from the Pyxis and the withdrawal
was not canceled, then the medication was administered to the patient.
Over the 60-day period, 2,737 analgesics were withdrawn. Each withdrawal
corresponded to a patient’s medical record number (MRN). The DNP student organized the data
by MRN and identified 627 unique patient MRNs. A manual electronic health record (EHR)
review of every 10th MRN was conducted (n = 62). Variables collected were age, total morphine
milliequivalent (MME) received on the OBS unit, admit date, the first 10 pain assessment scores
(on a scale of 0-10 with 0 being no pain and 10 being the worst possible pain) obtained on the
OBS unit, the date of each of the pain scores, and medications administered (drug name) at the
time of the pain score. Furthermore, if non-opioids were ordered while on the OBS unit (yes or
no) and whether the non-opioid was administered if ordered (yes, no, or NA) was collected. The
data was assessed to describe the population and identify trends.
The entire data set was analyzed for use patterns. Of the 2,737 analgesic withdrawals,
2121 (77%) were opioid-containing analgesics (see Appendix A, figure 1). Withdrawals were
categorized by medication (see Appendix 1, figure 2). Oxycodone was the most frequently used,
followed by dilaudid and acetaminophen. Oxycodone was used more than the non-opioid
analgesics (acetaminophen and ibuprofen) combined. Norco, dilaudid, and acetaminophen were
used equally. Acetaminophen was used 6 times more often than ibuprofen.
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The data set was analyzed by patient MRN. Ten percent, or 62, of the 627 unique patients
were selected for collection of variables by manual EHR review. The sample population (n=62)
ranged in ages from 18 to 99 of age with a mean age of 51.3 (standard deviation [SD] 19.8)
years.
The mean pain assessment score of the 62 patients upon arrival to the unit was 4.63 out of
10 (SD 3.3). Twenty-six (42%) patients were administered an analgesic after the first pain
assessment with a mean pain score of 6.23 (SD 2.49). Of the patients (n = 26) treated for pain
upon arrival, nearly 75% (n=19) were given an opioid-containing analgesic. Norco was the most
frequently used analgesic upon arrival (see Appendix A, figure 3). Pain scores provided by the
sample participants indicated patients were consistently administered analgesics at higher pain
scores (see Appendix A, figure 4).
The sample was analyzed to determine prescriber (physician, nurse practitioner [NP], and
physician assistant [PA]) and administrator (Registered Nurse [RN]) practices. Prescriber
practices were assessed for trends by identifying if a non-opioid was ordered. Administrator
practices were assessed for trends by identifying if the RN administered the ordered non-opioid.
Findings demonstrated 75% (n=47) of sample participants had a non-opioid ordered. Of those,
only 60% (n=28) were administered a non-opioid analgesic. In sum, non-opioids were either not
prescribed (n=15), or prescribed but not administered (n=19), resulting in 55% (n=34) of sample
participants receiving only opioid-containing medications for pain (see Appendix A, figure 5).
The entire data (N=2727) set was analyzed again for trends in analgesic use. The MRNs
were categorized into 3 analgesics receiving groups: opioid-only (oxycodone, morphine, and/or
dilaudid), multimodal (combination of opioid, acetaminophen, and/or ibuprofen), and non-opioid
only (see Appendix A, figure 6). Patients who received Norco or Tylenol #3 were placed in the
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multimodal category. A total of 463 (74%) patients received at least one opioid or opioidcontaining analgesic (Norco or Tylenol #3) during the 60-day period examined in this data. One
in 3 patients (n = 206) received only opioids (oxycodone, morphine, and/or dilaudid) for pain.
Problem Statement
Overreliance on opioids for the treatment of pain is a public health issue, that often leads
to devastating consequences. The OBS unit appears to practice this trend as well. Nearly 80% of
the analgesics used contain opioids and one third of its patients receive exclusively opioids for
pain treatment. The bottom line is pain is real, but opioids are dangerous, addictive, and have
been ineffective in improving self-reported pain despite significant use (CDC, 2016; Chapparo et
al., 2014). The opioid crisis cannot be solved on the OBS unit. However, OBS providers and
RNs have a duty to their patients to give them the best care available. The importance of treating
pain effectively while mitigating the devastating consequences of overreliance on opioids led to
the clinical question for this DNP project: Does implementation of an evidence-based pain
management protocol on the OBS unit produce efficacious pain treatment while simultaneously
reducing opioid consumption? This project will determine best practices as identified by the
highest level of evidence available in current literature and evaluate the new process by
comparing pre- and post-implementation data.
Evidence-based Initiative
To determine the best practices for pain management, a literature review was undertaken.
Providing effective pain management while simultaneously reducing overreliance on opioids will
be the primary focus of the project; therefore, evidence-based methods that effectively reduce
pain while shifting focus from opioid use was reviewed in the literature. Multimodal analgesia
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was central to this literature review as it has the potential to reduce opioid use by emphasizing
concomitant use of other analgesics with complimentary mechanisms of action.
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
guideline served as the framework for this literature review (Moher, Liberati, Tetzlaff, Altman,
& PRISMA Group, 2009). A comprehensive electronic search was conducted on the Cochrane
Library database and was limited to Cochrane reviews published in the English language during
the period of 2008 to 2017. The keywords used were multimodal, combined analgesia, pain,
opioid sparing, opioid consumption, and opioid reduction. Inclusion and exclusion criteria were
tailored to the characteristics of the OBS unit. The focus of the literature was to compare
multimodal analgesic therapy to monotherapy with one of the agents used in the intervention
group. The aim was fourfold:
•

Does multimodal analgesic therapy produce better pain management than analgesic
therapy with a single agent class?

•

Does multimodal analgesic therapy result in reduced opioid consumption?

•

Does multimodal analgesic therapy reduce frequency of administration of agents without
compromising pain management?

•

Does multimodal analgesic therapy produce more adverse events than use of a single
agent class?
The search yielded 150 Cochrane reviews (see Appendix B). After screening and in-

depth examination of the studies, 9 articles were included in the literature review (see Appendix
C). Findings of this literature review suggest multimodal therapy of at least 2 analgesics with
different mechanisms of action can produce better and longer pain management without
increasing adverse effects. Five reviews concluded that multimodal analgesic therapy is superior
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to use of single drug therapy. Four of these 5 were assessing acute postoperative pain (Derry et
al., 2013; Derry et al., 2013a; Moore et al., 2015; Toms et al., 2009). The fifth review was
assessing pain after wisdom teeth extraction (Baily et al., 2013). The remaining 4 reviews cited
limited availability of RCTs to make a definitive conclusion; however, each found evidence
supporting the superiority of multimodal analgesia over single drug therapy (Ashfar et al., 2015;
Chapparo et al., 2012; Derry et al., 2015; Ramiro et al., 2011).
A key finding of this review was ability to achieve at least a 50% reduction in pain when
using multimodal analgesia. This finding suggests that pain etiology is multifactorial and
requires treatment through multiple pathways. Combinations of NSAIDs, Acetaminophen,
Oxycodone, and Codeine demonstrated greater efficacy of pain management than single drug
therapy in postoperative and dental pain (Baily et al., 2013; Derry et al., 2013; Derry et al.,
2013a; Moore et al., 2015; Toms et al., 2009). An antispasmodic is the only drug found in this
review that does not appear to make a difference when used in multimodal therapy (Ashfar et al.,
2015; Chapparo et al., 2012).
Multimodal analgesia also increased the time needed for remedication for pain.
Increasing the time between analgesia doses decreases the patient’s exposure to analgesics. This
is particularly beneficial because over-exposure to opioids can cause a state of opioid-induced
hyperalgesia (OIH). OIH is a response to opioids where a patient may develop nociceptive
sensitization from opioid exposure (Lee, Silverman, Hansen, & Patel, 2011). In short, high
exposure to opioids can lead to a paradoxical response of increased pain. Thus, the benefit of
producing longer response to pain management through multimodal analgesia decreases the
exposure to potentially pain-inducing analgesia.
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None of the reviews examined opioid consumption. Two reviews, however, presented
evidence that the addition of a nonopioid to an opioid drug provided more efficient and effective
analgesia (Derry et al., 2013; Moore et al., 2015). For example, Derry et al. (2013) found that the
addition of Ibuprofen to Oxycodone produced a higher level of pain management efficacy and
significantly longer time to remedication for pain than Oxycodone alone. Thus, the addition of
Ibuprofen to Oxycodone can result in a reduction in total opioid consumption over the course of
the painful experience. While Moore et al. (2015) demonstrated that the addition of
Acetaminophen 650mg to Oxycodone 10mg was more efficacious than Oxycodone at a higher
dose (15mg) given in isolation (NNT 2.7 [2.4 to 3.1] compared to NNT 4. 6 [2.9 to 11],
respectfully). Furthermore, a multimodal regimen of two nonopioids (Ibuprofen 400mg +
Acetaminophen 1000mg) had a lower NNT (1.5 [1.4 to 1.7]) than Oxycodone 15 mg taken in
isolation (NNT 4.6 [2.9 to 11]) (Moore et al., 20150. These are promising results, suggesting that
strategic use of analgesics can produce the dual benefit of greater analgesia and reduced opioid
consumption.
Adverse events had either no difference between groups or significantly less in the
groups receiving multimodal therapy. Thus, adverse events should not be a reason to avoid
multimodal therapy for pain. However, NSAID therapy is often avoided due to the fear of its
adverse events. Concerns about increased risk of bleeding (from inhibition of platelet
aggregation) postoperatively and gastrointestinal effects (particularly in the elderly) may prevent
a clinician from using NSAIDs for pain (Solomon, 2016). NSAIDs used short term (<10 days) at
the lowest effective dose, however, is relatively safe (Aminoshariae, A., Kulild, J. C., &
Donaldson, 2016). Lower doses of Ibuprofen can be as effective as higher doses. Moore et al.
(2015) found evidence that ibuprofen 400mg (NNT 2.1 [1.9 to 2.3]) can be as or more effective
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than ibuprofen 600mg (NNT 2.7 [2.0 to 4.2]). In sum, multimodal therapy with an NSAID is
effective, does not produce more adverse events, and can be safe if used correctly.
The current literature underscores the potential of multimodal analgesic therapy.
Dependence on opioids for pain treatment has primarily been based on expert opinion. This
literature review demonstrated multimodal analgesic therapy is an efficacious alternative
approach to overreliance on opioids for pain management in certain conditions. It also
highlighted the importance that combining analgesics with different mechanisms of action can
increase time to remedication without inducing additional adverse effects. Opioids still play an
important role in pain management; however, these drugs should no longer be considered the
primary tool for pain treatment. Instead, using opioids in conjunction with other drugs can
intensify analgesia and may increase the duration of its therapeutic effect. These findings offer
evidence to improve pain management practices and provide a strategy to treat pain without
perpetuating the opioid crisis on the OBS unit.
Conceptual Model
To assist in the successful implementation and sustainability of this project, both a
theoretical and an implementation conceptual model will serve as the guide for project
application. Conceptual models are useful because they highlight elements crucial to the success
of a project that may have not been otherwise considered or addressed. The theoretical model
used for this project is the Promoting Action on Research in Health Sciences (PARiHS)
framework. The implementation model for this project is Kotter’s 8 steps of change.
Theoretical Model - Promoting Action on Research in Health Sciences Framework
The phenomenon of the reliance on opioids despite overwhelming evidence and
professional consensus is best viewed through the PARiHS framework. The PARiHS framework
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was created in 1998 for the purpose of providing a checklist for successful implementation of
research into practice (Kitson, Harvey, & McCormack, 1998). Kitson et al. (1998) argue that
successful implementation of research into practice is a function of three core elements –
evidence, context, and facilitation. Far too often implementation of evidence-based practice has
failed because the complexity of the change process has not been captured (Kitson et al., 1998).
Kitson et al. (1998) propose that the context of the environment and the way in which the change
process is facilitated is as important as the level and rigor of evidence being implemented. The
following equation emerged from the creation of this framework:
•

SI = f (E,C,F)
o where SI = successful implementation, f = function of E = evidence, C = context,
and F = facilitation.
Evidence. Kitson et al. (1998) defines evidence as the combination of research, clinical

expertise, and patient choice. Research can range from low quality (anecdotal or descriptive) to
high quality (RCTs, systematic reviews, evidence-based guidelines). Clinical experience, or
professional consensus, involves a spectrum of low consensus (divided expert opinion) to high
consensus (consistency of view). Finally, patient preference can range from low input (patient’s
opinion completely overlooked) to high input (patient’s feedback consistently included in
decision making). See Appendix D A to view the continua of evidence.
Context. Context is defined as the environment or setting where the proposed change
will occur (Kitson et al., 1998). Context is the underlying forces at work that give the
environment its character and feel. Context is composed of culture, leadership, and the
measurement of systems and services (Kitson et al., 1998). Each of these elements run along a
continuum of low to high context (see figure 2 B the view the continua of context). Culture is
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considered high when it is people-centered and emphasizes continual learning as opposed to task
driven and low regard for the people who work and are cared for in the setting. High context of
leadership occurs when everyone has clear roles, effective organizational structure is in place,
and team work is evident. High context of measurement occurs when there are routine,
established systems of measuring performance.
Facilitation. Facilitation refers to a technique by which a person can make things easier
for others (Kitson et al., 1998). The facilitator is the person who provides support to help others
change their attitudes, habits, skills, ways of thinking, and workflow in order to make the change
easier. The facilitator must help people understand why the change is necessary and motivate
them to achieve the desired outcome. Successful facilitation requires the facilitator to possess
high levels of three core elements – characteristics, role, and style (Kitson et al., 1998). Personal
characteristics of openness, respect, and credibility, clarity surrounding the facilitator’s role, and
flexible, consistent style are vital for successful facilitation. See figure 2 C to view the continua
of facilitation.
Successful Implementation. For successful implementation, consideration of each
element (evidence, context, and facilitation) is vital. Implementation of a project has the best
chance for success when there is high evidence, high context, and high facilitation. As previously
discussed in the evidence-based initiative section, the evidence for this DNP project is the
highest level (systematic reviews). To better understand the context and effective methods of
facilitation for this project, an organizational assessment and analysis of strengths, weaknesses,
opportunities, and threats (SWOT) of the OBS unit was undertaken.
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Implementation Model – Kotter’s Eight Step Change Model
When implementing this project, Kotter’s Eight Step Change Model will serve as the
guiding framework to promote the success of this practice change (see Appendix E). Kotter
created this model after observing more than 100 companies attempt transformation (Kotter,
1996). In response to his observations, he identified three phases, consisting of 8 steps, that are
necessary for successful change in an organization (Kotter, 1996).
Creating Climate for Change. The first phase of Kotter’s 8 step process is creating
climate for change. This first phase consists of the first three steps geared to transforming the
climate to make it ready for change. The first step is creating a sense of urgency (Kotter, 1996).
To create a sense of urgency, the facilitator must inspire everyone else that there is an
opportunity that must be acted on immediately (Kotter International, 2017). The second step is
building a guiding coalition (Kotter, 1996). During this step, a volunteer army who believes in
this change is enlisted to champion the project (Kotter International, 2017). The third step, and
final in creating a climate for change, is creating a vision for change (Kotter, 1996). When a
vision is created, people can focus on it more clearly and adapted to the strategies necessary to
achieve the vision (Kotter International, 2017).
Engaging and Enabling the Organization. The second phase of Kotter’s 8 Step Change
Model is engaging and enabling the organization. This second phase also consists of the next
three steps of the model for its achievement. The fourth step is communicating the vision for
buy-in (Kotter, 1996). At this point, the organization and facilitator need to make sure the people
understand the vision and accept the strategy to obtain it (Kotter International, 2017). The fifth
step is empowering action (Kotter, 1996). During this step, barriers to action must be removed to
promote the freedom necessary to create real impact (Kotter International, 2017). The sixth step,
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and final in engaging and enabling the organization, is creating quick wins (Kotter, 1996).
Recognizing short-term successes energizes the champions and promotes buy-in from everyone
involved (Kotter International, 2017).
Implementing and Sustaining for Change. The last phase of Kotter’s 8 Step Change
Model is implementing and sustaining for change. This final phase consists of the last two steps
in the model. The seventh step is building on the change (Kotter, 1996). At this point in the
change process, it is important to not let up. The first successes of the process have earned
credibility for the change and must be used to accelerate for more improvement of systems,
structures, and policies (Kotter International, 2017). The eighth and final step is making it stick
(Kotter, 1996). This is when the new behaviors of the process are connected to the success of the
organization (Kotter International, 2017). By this time, it is important to ensure that the new
behaviors become strong enough to replace old habits.
Feasibility Assessment of the Organization
Successful implementation of a practice change in any organization can be challenging.
A feasibility assessment of the organization’s ability to accept change is helpful prior to identify
facilitators or barriers to change. To assess feasibility, several factors were identified and
accounted for, such as the organizational culture, external environment, and unit climate. To
systematically account for these factors, and organizational assessment of the OBS unit using the
Burke-Litwin Causal Model (see Appendix F) and a SWOT analysis (see Appendix G) was
performed.
Burke-Litwin Causal Model
The Burke-Litwin Causal Model was chosen as it can be used to define and identify
organizational dimensions which are linked causally in order to promote and achieve change
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(Burke & Litwin, 1992). Burke and Litwin (1992) hypothesize that there are two distinct sets of
dynamics within an organization – climate and culture. Climate refers to the conscious
perceptions employees have about how the local work environment is managed and how well
day-to-day colleagues collaborate (Burke & Litwin, 1992). Culture is the underlying set of
values and norms in the organization, a collection of overt and covert rules that guide
organizational behavior, and is more background than climate (Burke & Litwin, 1992). The
variables that define organizational climate are transactional factors; and those that define culture
are transformational factors.
Transformational factors are the most influential forces of change for an organization.
Transformational factors include the external environment, mission and strategy, leadership,
organizational culture, and individual and organizational performance (Burke & Litwin, 1992).
Of these factors, Burke and Litwin (1992) argue that the external environment is the most
persuasive transformational factor to drive change within an organization.
Transactional factors are the structural components of a work environments climate.
Transactional factors consist of everyday exchanges between members of the organization.
These factors explain the reciprocity of human behavior – in other words, “You do this for me
and I’ll do that for you” (Burke & Litwin, 1992, p. 530). Transactional factors include structure,
management practices, systems, work unit climate, task and individual skills, motivation,
individual needs and values, and individual and organizational performances (Burke & Litwin,
1992).
The 12-distinct transformational and transactional factors of the organization and OBS
unit were assessed. After assessment, several facilitators and barriers to this project were
identified. The assessment also exposed an opportunity to improve pain management through use
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of non-opioids on the unit. The external environment revealed an opioid crisis, making the
overreliance on opioids in the OBS unit a significant problem. The mission and strategy,
leadership, culture, structure, management practices, work unit climate, individual abilities and
values of the staff, motivation, and performance measures of the organization serve as facilitators
to the practice change. The only potential barrier identified lies within the systems of the
organization. Presently, non-opioid analgesics such as acetaminophen or ibuprofen, may only be
given for mild pain, identified through a reported pain score of 1-3 (on a scale of 0-10) or per
patient’s description of the pain. Oral opioids, such as hydrocodone and oxycodone, should be
given for moderate pain, identified through a reported pain score of 4-7 or per patient’s
description. Intravenous opioids, such as morphine or dilaudid, should only be given for severe
pain, identified from a reported pain score of 8-10 or per patient’s description. As this policy is
currently written, the RN would not be able to administer an opioid and a nonopioid analgesic
simultaneously. This is a barrier that must be addressed with as part of this project.
Strengths, Weaknesses, Opportunities, and Threats Analysis
A SWOT analysis is a synthesis for an organization’s current state. It involves
identification of an organization’s internal strengths and weakness, and its external opportunities
and threats. Internal strengths of an organization are what gives the organization a competitive
edge over its competitors (Fallon, 2017). Weaknesses of an organization are internal factors the
organization can influence and correct. Opportunities refer to forces in the external environment
that the organization has no control over yet influences how an organization functions (Fallon,
2017). Growth opportunities can be considered, and once identified, should be invested in.
Threats are also forces of the external environment that an organization has no control over yet
can influence and cause trouble to organization if not anticipated (Fallon, 2017). Awareness of
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the organization’s SWOT analysis identifies areas organization can build on or mitigate when
seeking improvement from its current state. As shown in figure 2, a SWOT analysis was
performed on the OBS unit, specifically in relation to a pain management practice change.
Strengths of and opportunities for the OBS unit were identified. Strengths of the OBS
unit include its providers, nurses, and its affiliation with Spectrum Health, a nationally ranked
healthcare system, which provides support for process improvements. Opportunities for the OBS
unit in relation to improving its pain management practices include public attention on the opioid
crisis and need for better practices, potential to reduce opioid-misuse related hospitalizations, and
enhancement of quality care by introducing evidence-based practice. These must be capitalized
on as they can facilitate an organizational practice change.
Weaknesses of and threats to the organization was also identified. It is important to
address these in order to mitigate their effect on a practice change project. Weakness of the OBS
unit that could hinder a pain management practice change. The weaknesses include the
simultaneous implementation of Epic in November, variety of pain causing conditions patients
present with, prescriptive analgesic orders in the electronic health record, and limited patient
length of stay. Threats to the OBS unit in relation to a pain management practice change include
patient desire for opioids, reimbursement tied to patient satisfaction, and potential that the entire
staff will not buy-in to the change. The weaknesses and threats must be addressed during the
practice change so their effect is mitigated.
Project Plan
Purpose of Project
The purpose of this DNP project is to implement multimodal analgesia, an evidencebased pain management practice, into the standard of care on the OBS unit. This project will
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seek to answer the clinical question: Does promotion of multimodal analgesia, an evidence-based
pain management method, on the OBS unit produce efficacious pain treatment while
simultaneously reducing opioid reliance and consumption?
Objectives and Implementation Strategies
Objectives for this DNP project will be aimed at promoting uptake of multimodal pain
management practices among the staff. Evidence-based implementation strategies will be used to
support these objectives. The following are the objectives with strategies for achievement that
will be used for this DNP project.
1. Build a coalition prior to implementation on December 1, 2017
Identifying and utilizing change champions within an organization is an evidence-based
strategy for increasing uptake of a practice change (Kaasalainen et al., 2015). Implementation
science experts define building a coalition as recruiting and cultivating relationship with others
to partner in the implementation effort (Powell et al., 2015). Steps to achieve this objective
include:
•

Presenting multimodal analgesia evidence to the OBS unit Shared Leadership Committee
on October 18, 2017. The RNs at this meeting reported buy in for this change and agreed
to serve as change champions.

•

Cultivating relationships with the OBS unit charge RNs and requesting their participation
in the promotion of this project. An email will be sent to the charge RNs prior to
December 1, 2017 with steps on how to promote the project during shift huddles.

•

Meeting with the medical director to discuss evidence for the project. The medical
director is the local opinion leader for the OBS unit providers. Having his partnership for
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this project will help influence colleagues to adopt multimodal therapy into the standard
of care (Powell et al., 2015).
2. Educate the providers and RNs on multimodal pain management by December 1, 2017
Educating the providers and RNs about the evidence supporting multimodal analgesia is
essential to this DNP project. Educational meetings combined with other interventions such as
audit and feedback can help change professional behaviors and improve patient health outcomes
(Forsetlund et al., 2009). Steps to achieve this objective include:
•

Educating the RNs will occur during the November staff meetings. A 15 minute
presentation about the evidence supporting multimodal pain management and strategies
to promote practice into standard care will be conveyed.

•

Educating the providers through email (see Appendix H for sample email).
Unfortunately, the providers do not have OBS unit specific staff meetings; however,
distributing educational materials electronically is a recognized implementation strategy
by implementation science experts (Powell et al., 2015). A peer reviewed published
article with multimodal analgesia evidence (Teater, 2014) will be included.

•

Creating an educational flyer and dispersing it strategically on the OBS unit. The flyer
will include evidence for multimodal pain management, tips and reminders for providers
to order several agents with different mechanisms of action, and scripting for providers
and RNs to inform patients about the benefits (see Appendix I for sample flyer). Printed
educational materials are effective strategies to promote process changes (Farmer et al.,
2008). Strategic locations include the nurses’ station, computers where providers chart,

the DCI board, and the break room. An additional copy will also be provided for each RN
and placed in his or her mailbox.

IMPLEMENTION OF EVIDENCE-BASED PAIN MANAGEMENT

26

3. Create and embed multimodal medication order (oxycodone and acetaminophen) into OBS
unit frequently used order sets by December 1, 2017.
Implementation of best practices into standard care is increased with the use of order sets
(O'Connor, DeCaire, & Friedrich , 2005; Ozdas et al., 2006; Stantolin & Boyer, 2004). With the
implementation of Epic on November 5, 2017, implementing an evidence-based analgesic orders
that allow for increased multimodal analgesia into existing OBS order sets will be delayed
several weeks. Steps to achieve this objective include:
•

Meeting with the pharmacist in November, 2017 to create evidence-based multimodal
analgesic order indication

•

Meeting with the OBS unit CNS and medical director in December, 2017 to present
evidence to support the change for acetaminophen and ibuprofens indication within
the OBS unit order sets (see Appendix J).

4. Perform weekly audit and feedback for 60-days after implementation, starting after
December 1, 2017.
Audit and feedback is the summary of clinical performance data that allows clinicians to
monitor, evaluate, and modify behavior (Powell et al., 2015). Audit and feedback is most
effective when baseline adherence to recommended practice is low and feedback is delivered
intensely (Jamtvedt, Young, Kristoffersen, O’Brien, & Oxman, 2006). Steps to achieve this
objective include:
•

The pharmacy technician providing the DNP student with a weekly Pyxis report of all
analgesics withdrawn on the OBS unit

•

The DNP student arranging the report by individual patient according to MRN
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Identifying percentage of patients who received opioid-only, multimodal, and nonopioid-only analgesic therapy

•

Posting results on the DCI board for RNs to discuss during shift huddle and sending
results to providers via email.

•

Providing feedback on how to modify behavior to promote multimodal analgesic
practices to RNs and providers.

5. Deliver final report on how the objectives achieved the purpose of this project and how it

answered the clinical question by March 30, 2018.
Capturing and distributing local knowledge is an implementation strategy that seeks to share
how clinicians changed practices in their settings (Powell et al., 2015). This strategy can
encourage others to build on successes and promote quality improvement in other settings.
Linking behaviors to successes is a crucial step in making behaviors part of the standard of care
(Kotter, 1995). Steps to achieve this objective include:
•

Posting results for OBS unit staff to see on the DCI board, at the nurses’ station, and in
the break room.

•

Presenting results to RNs during March, 2018 staff meetings with deliberate credit given
to RN’s behaviors as essential to the results.

•

Disseminating results to OBS providers via email by March 30, 2018 with deliberate
credit given to the OBS providers behaviors being essential to the results,

•

Presenting results to organization’s Pain Management and Opioid Prescribing Steering
Committee.
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Type of Project
This DNP project is a quality improvement project. A quality improvement project
changes the delivery of healthcare through a systematic method in order to produce improved
patient experience and outcomes (Tasker, 2013). This project seeks to improve the delivery of
pain management on the OBS unit to reflect best evidence. By promoting multimodal pain
management, patients will receive effective pain relief while limiting the harm that can occur
with the overreliance on opioids.
Settings and Resources Needed
This DNP project will take place on an OBS unit in a Midwestern freestanding hospital.
Resources necessary to complete this DNP project include technology, people, and educational
materials. Technology necessary to complete this project includes the EHR, Webex, email, and
Survey Monkey. People needed to complete this project include OBS staff (RNs and Providers),
OBS leadership (nurse manager, educator, CNS, and medical director), pharmacist, and
pharmacy technician. Educational materials needed are flyers printed at fedex and weekly
printed updates posted on the DCI board.
Design for Evidence-based Initiative
The design of the evidence-based initiative is based upon the PARiHS framework. The
DNP student considered the three core elements of the PARiHS framework when designing the
evidence-based initiative for this project (see figure 2).
Evidence. Successful implementation of research into practice is more likely when the
evidence is at the highest level. As established, the research for multimodal analgesic therapy has
been demonstrated in several systematic reviews. Professional consensus for multimodal therapy
for pain is also well established. The Joint Commission and the Institute for Clinical Systems
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Improvement recommend the combination of opioids with non-opioids in order to reduce
reliance on opioids for pain (The Joint Commission, 2012; Thorson et al., 2014). Furthermore,
patient preferences are not to be ignored with this initiative. RNs and providers will be expected
to involve the patients in the treatment of their pain. Staff will be encouraged to share the
evidence for multimodal analgesia with the patient when presenting them with non-opioid
alternatives or adjuncts for their pain treatment. Scripting on how to address patients concerns
regarding multimodal analgesia will be provided for the staff to use when presenting this
initiative to patients. Thus, confidence in the evidence this initiative is based upon underlies the
foundation of this DNP project.
Context. There is a high level of context for this initiative as identified during the
organizational assessment. This DNP project initiative will build upon the high context already
established on the OBS unit (see Appendix . The initiative will emphasize patient-centered care
by encouraging the staff to partner with the patients to promote and utilize multimodal analgesia.
The roles will be clearly defined during the education phase of the project. The providers will be
expected to order both opioid and non-opioid options for pain. The RNs will be expected to
utilize a multimodal regimen according to the patient’s individual needs. Teamwork will be
encouraged by having providers and RNs work together to discuss the patient as an individual –
such as, is this patient a candidate for an NSAID? The RN will be encouraged to ask the provider
for a non-opioid order if the provider has not ordered one. The provider will be encouraged to
give the RN advice on the etiology of the patient’s pain and which strategies would be most
effective at treating it. Measurement on progress through weekly feedback will be provided by
the DNP student to the RNs and providers on how often multimodal analgesia was utilized. This
feedback will be placed on the DCI board for RNs to review every shift. A weekly email of the
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pilot project progress will be sent to the providers. If necessary, tips on how to improve
multimodal analgesic utilize will be provided in real-time.
Facilitation. The facilitator is vital to the success or failure of the implementation of
research into practice (Kitson et al., 1998). The DNP student will serve in the facilitator role. To
increase facilitation, the DNP student recognized a barrier to remove. The DNP student
identified during the needs assessment that Oxycodone was the most frequently used opioid on
the OBS unit. Evidence exists that demonstrates Acetaminophen given with small dose
Oxycodone (5-10mg) provides superior pain relief than large dose Oxycodone (15mg) given
alone (Moore et al., 2015). However, Acetaminophen was rarely given in conjunction with
Oxycodone because the order for Acetaminophen indicated it could only be given for mild pain,
and Oxycodone could only be given for moderate to severe pain. The DNP student will remove
this barrier and make this process easier on the providers and RNs. To do this, a new order set
that links Oxycodone to Acetaminophen for moderate to severe pain will be created. This order
set will then be inserted into frequently used OBS unit Epic order sets, facilitating the use of
multimodal analgesia on the unit.
To further assist in facilitation of this DNP project, the DNP student will display respect
and flexibility to ensure the success of this initiative. The DNP student will listen to and address
concerns and suggestions for the project during the educating phase and throughout the pilot
period. The DNP student will remain present during the pilot period by spending at least 8 hours
per week on the unit. The DNP student will be a credible resource by remaining apprised on the
progress of the project and all pertinent research related to the subject. The DNP student will be
empathetic to any disruption of workflow this project may impact and respond immediately.
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Participants
The participants in this DNP project are all patients treated pharmacologically for pain
while on the OBS unit. The providers and RNs are encouraged to emphasize multimodal
analgesia to address the patients’ pain complaints. Patients treated for pain will be determined by
a Pyxis report. Any patient that had an analgesic withdrawn for them while they were on the
OBS unit will be included in this pilot project.
Measurement: Sources of Data and Tools
Measuring data is essential to evaluation of the project objectives, purpose and clinical
question. Data will be collected through surveys, Pyxis report, EHR chart review, checklists, and
observation. Several surveys will be created and used as tools to measure data.
Each objective will be measured. To determine the extent the coalition of change
champions promoted multimodal pain management, a checklist and observation will be the tools
for data collection. A shift huddle checklist will be put in the charge RN office for the charge RN
to initial if the staff was updated on the weekly audit and feedback report put on the DCI board.
The DNP student will also observe 4 shift huddles per week and note if the project is discussed at
shift huddle. RN education will be measured through a pre- and post-survey at the November
staff meeting (see Appendix K for survey sample). For RNs that attend the staff meeting in
person, the surveys will be provided on paper. For RNs that attend the staff meeting through
WebEx, the polling feature on WebEx with the survey questions will be administered
immediately before and after the education. Education of the providers will be evaluated through
SurveyMonkey. The providers will be asked to fill out the SurveyMonkey after reading the email
education. The survey will ask if they read the education, if any of the information was new to
them, and if they plan to change their behaviors after learning about the initiative. Use of the
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multimodal medication order will be determined by EHR chart review. Data for the audit and
feedback will be provided by the pharmacy technician. She will provide the DNP student with a
list of analgesics withdrawn from both unit Pyxis’ the previous 7 days. The DNP student will use
this report and an EHR chart review to audit and provide feedback for the staff every week.
The purpose of the project is to promote uptake of multimodal pain management
practices. This will be measured by determining how many patients received multimodal
analgesia compared to those receiving opioid-only treatment. Data to inform this measurement
will come from a Pyxis report generated by the pharmacy technician. Report on the following
analgesic withdraws will be requested: morphine, dilaudid, oxycodone, Norco, Tylenol #3,
tramadol, acetaminophen, Toradol, and ibuprofen. The report will be organized by MRN.
Combination of analgesics withdrawn for each MRN will be determined and classified as opioidonly, multimodal, or non-opioid only. An increase in multimodal and decrease in opioid-only
pain management will communicate that multimodal analgesia pain management practice
promotion has been effective.
The clinical question this project seeks to address is whether multimodal pain
management practices produce efficacious pain management while simultaneously reducing
opioid reliance and consumption. Efficacious pain management will be determined through EHR
chart review and patient satisfaction surveys. An EHR chart review will be conducted to
determine the average pain assessment scores of patients receiving multimodal analgesic therapy.
These scores will be compared to the scores of patients receiving opioid-only therapy. The
monthly patient experience report will also be used to determine whether pain management was
effective. A patient survey question on the patient experience report asks how well pain was
controlled. Answers to this question from December 2017 and January 2018 will be collected.
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Opioid consumption information will also come from the Pyxis withdrawal report. The ratio of
opioid-containing withdrawals to non-opioid withdrawals will measure opioid reliance. The ratio
of opioid-containing analgesic withdrawal per participant will be determined as a measure of
opioid consumption.
Steps for Implementation of Project
To ensure that the clinical question, purpose, and objectives of this DNP project are
addressed, Kotter’s 8 step change model will serve as the guide. See Appendix L for the timeline
of each step.
1. Create a sense of urgency: Beginning September, 2017, meetings with key stakeholders
began. The DNP student met with the OBS manager, educator, and CNS several times
between September and October, 2017 to begin planning the project.
2. Create a coalition: The DNP student met with OBS unit RN leaders at the unit shared
leadership meeting on October 18, 2017. These RNs agreed to champion the project.
3. Create a vision: On October 26, 2017, the vision for this project will be presented and
clarified among the project team.
4. Communicate the vision: Education for the project will be provided during the week of
November 13, 2017. The vision of the project will be communicated in the RN staff
meeting and through an email to the OBS providers.
5. Empower action: By December 1, 2017, a multimodal medication order that links
oxycodone and acetaminophen for use for moderate to severe pain will be incorporated in
any OBS unit order set that previously featured oxycodone alone. This will help remove
that barrier of acetaminophen being indicated for only mild pain.
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6. Create Quick Wins: Every Friday after December 1, 2017, a weekly audit and feedback
will be posted on the unit DCI board and via email to the OBS providers. This will
encourage the staff to build on successes.
7. Building on the change: Although the DNP student will discontinue providing weekly
progress reports 60-days after implementation, a final review will be provided for the
staff by March 1, 2018. The multimodal medication order will remain in the OBS order
sets unless it is determined problematic. The final review will also be presented to the
organization Pain Management and Opioid Steering Committee by March 30, 2018.
8. Make it stick: If determined successful, the multimodal medication order and education
will be promoted for use in other organizational settings. A new DNP student will be
designated to promote continued initiatives by April 1, 2018. Additionally, educational
flyers will be placed in all new OBS unit RN orientee’s education folder to ensure new
RNs get the same education as the current RNs.
Project Evaluation Plan
The evaluation of this DNP project will occur throughout implementation and 60-days
after the start of implementation. Evaluation of the objective occur throughout the
implementation. The coalition strategy will be considered a success if the charge RN promotes
multimodal analgesia during at least 75% of shift huddles, as measured by the checklist.
Observation of four weekly shift huddles can also evaluate change champion participation.
Education of RNs will be evaluated by determining whether an increase of survey scores is seen
in the post-survey. Education of providers will be evaluated by how many providers respond to
the SurveyMonkey, and how many of them report they will change behaviors to support the
project. Utilization of multimodal medication order will be evaluated for frequency of use. Chart
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review will be conducted on patients who had the multimodal medication order. If 85% or more
of these patients received multimodal or non-opioid only therapy, the multimodal medication
order will be considered a success. If utilization is low, efforts to promote increased use will
occur during weekly feedback. Evaluation of audit and feedback will be determined by
observation. The audit will be presented as charts and graphs, including frequency of analgesic
withdrawn and percentage of patients receiving opioid-only, multimodal, or non-opioid therapy.
Success of the audit and feedback strategy will be determined if behaviors are modified in
response to feedback as evidenced by progressively improving audits, such as each week more
patient receive multimodal therapy and less receive opioid-only therapy.
Evaluation of whether the purpose of the project was achieved will occur 60-days after
the start of implementation. Implementation of multimodal pain management practices will be
considered successful if participants receiving opioid-only therapy decreases 50% compared to
pre-implementation data. Prior to implementation of this DNP project, 33% of patients treated
for pain on the OBS unit received exclusively opioids for pain. If at the end of 60-days, the
percentage of people receiving exclusively opioids for pain decreases to 16.5% or less, than the
purpose will be achieved.
Evaluation of this project’s success will ultimately be determined by how it answered the
clinical question after 60-days. Multimodal analgesia will be considered an effective pain
management practice if the pain assessment scores of patients who received multimodal
analgesia are equal to or lower than the scores of patients who received opioid-only therapy. The
pain treatment satisfaction question results from December 2017 and January 2018 on the patient
experience report will be compared to the satisfaction results prior to implementation. If the
satisfaction scores after implementation are equal to or greater than the pre-implementation
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scores, then multimodal analgesia will be considered an effective pain management practice.
Multimodal analgesia practices effect on opioid reliance will be considered effective if the
disparity between opioid-containing withdrawal and non-opioid withdrawals decreases. Prior to
implementation, 4 opioid-containing analgesics were withdrawn to every 1 non-opioid
withdrawal. If the ratio becomes 3 opioid-containing withdrawals or less to every 1 non-opioid
withdrawal, multimodal analgesia’s effect on opioid withdrawal will be considered a success.
Multimodal analgesia practice effect on opioid consumption will be considered effective if the
ratio of opioid to person treated for pain on the OBS unit decreases. Prior to implementation,
there were 2121 opioid-containing withdrawals for 627 people treated for pain on OBS over a
60-day period. This ratio results to 3.38 opioids consumed per person treated for pain. If the ratio
decreases by 10%, or 3 opioids or less consumed per person treated for pain, then multimodal
analgesia will be considered successful at decreasing opioid consumption.
Ethics and Human Subjects Protection
Ethical consideration was undertaken for this project. Application for this project was
submitted to Grand Valley State University Human Research Review Committee’s for
Institutional Review Board (IRB) and the organization’s IRB. The GVSU IRB determined this
project did not meet the criteria of human research and was approved (see Appendix M). The
organization IRB determined the same, and approved this as a quality improvement project (see
Appendix N).
Budget
The budget for this DNP project must be addressed (see Appendix O). Most of the costs
for this project with be donated by the DNP student serving as the project manager. The DNP
student will be donating the time to create an education plan (20 hours), educating RNs at 4
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separate staff meetings (4 hours), generating an informational flyer (4 hours), educate the
providers via email (2 hours), and 8 hours per week during the 60-pilot period (8 weeks total).
As the DNP student is an RN with 7 years’ experience and not yet DNP-educated, the hourly rate
for the DNP student’s time will be calculated as $30 per hour (Pay Scale, 2017). The total
donated cost for the project manager is $2,820. Furthermore, the Presidential Research Grant
provided $114.80 to pay for educational flyers, a professionally printed white paper, and a binder
to give to the unit after the project with steps for sustainability.
Other resources include time invested by staff to make this project possible. Two clinical
nurse specialists (CNS) have been consulted to ensure that this DNP project is compliant with
Joint Commission standards. The average hourly rate for a CNS is $48 (Salary.com, 2017a). A
pharmacist was consulted to help make an order set to improve ease of implementation. An
average pharmacist hourly rate is $60 (Salary.com, 2017b). In order to effectively educate the
RNs of the project, 15 minutes will be added onto one staff meeting. Using a $30 hourly rate for
30 RNs to be educated for 15 minutes would cost the organization $225. Educating the providers
could require up to 30 minutes of them reading the materials provided to educate them on the
project. An average NP and PA hourly wage is $49 (Salary.com, 2017c). An ED physician
hourly wage is $131 (Salary.com, 2017d). The pharmacy technician would spend one hour per
week to generating the weekly pyxis report during the 8-week pilot project. The average hourly
wage for a pharmacy technician is $16 (Salary.com, 2017e). The rest of the education will occur
twice daily during shift change and will not add any additional expenses to the organization.
Potential cost savings of a plan to mitigate the OBS unit’s contribution to the opioid
epidemic must be considered as well. In Michigan, the rate of opioid-related admissions was
229.6 per 100,000 people in 2014 (Weiss et al., 2016). The population of Grand Rapids in 2014
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was 194,321 people (United States Census Bureau, 2017). Using these statistics, it is calculated
that in 2014 there were 445 opioid-related hospital admissions for the people in Grand Rapids.
The average hospital length of stay when admitted for an opioid-related overdose is 3.8 days and
costs $29,497 (Bachhuber, Saloner, Cunningham, & Barry, 2014). Thus, if at least one opioidrelated hospital admission could be averted in the future by implementing this DNP project, then
nearly $30,000 in hospital costs could be mitigated. Furthermore, if just one opioid-related ED
visit could be prevented, then $3,640 additional costs could be mitigated (Bachhuber et al.,
2014).
Stakeholder Support and Sustainability
Prior to beginning the DNP project at this site, stakeholder support was investigated. The
site advisor for this project provided the DNP student with a letter of support (see Appendix P).
Upon conducting this project at the site, more stakeholder support was gained. A member of the
organization’s Pain Management and Opioid Prescribing Steering Committee met with the DNP
student several times for consultation. The DNP student has also been inviting to sit in on the
Steer Committee monthly meetings as strategies to combat the opioid crisis will be discussed.
Further support was gained from the OBS unit CNS who supports implementation of this
evidence-based initiative organization-wide if the quality improvement project is successful.
Sustainability of this DNP project can be achieved several ways. First, the multimodal
medication order created to facilitate multimodal pain management on the OBS unit will remain
in place after completion of project. Second, the results of the project will be presented during
the organization’s Pain Management and Opioid Prescribing Steering Committee monthly
meeting in March 2018. Finally, hand off of the project to a new DNP student will take place if
the organization continues interest.
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Implications for Practice
There are major implications for practice that can be addressed with this DNP project.
The opioid crisis is an established issue. Overreliance on opioids for the treatment of pain has led
to devastating outcomes. Although this DNP project will not solve the opioid crisis, it will ensure
that one facet of the healthcare system is doing its part to change its pain management practices
to reflect evidence, not expert opinion. Taking the focus off of opioids as the only option for pain
and shifting it to a multimodal approach has the potential to decrease opioid use entirely while
achieving greater pain relief. Patients treated on the OBS unit during this project will be educated
on evidence-based pain relief and can take that knowledge home with them. If this project
prevents even one person from developing opioid dependence, then it has achieved its goal.
Plans for Dissemination of Outcomes
The outcomes of this DNP project will be disseminated via various methods. The DNP
project will be presented as part of the DNP student’s final defense in March, 2018. Anyone
from the organization and community are invited to attend. The outcomes will also be
disseminated during a monthly meeting for the organization’s Pain Management and Opioid
Prescribing Steering committee. At this meeting, the DNP student will present recommendations
for next steps, including disseminating this project organization wide. Finally, the DNP student
will seek out opportunities to disseminate these outcomes to relevant professional journals and
conferences.
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Appendix A
OBS Unit Needs Assessment

Withdrawals from Unit Pyxis
616 (22.5%)
Non-opioid
analgesics

2121 (77.5%) Opioid
containing analgesics

Figure 1. Total withdrawals from the Unit Pyxis’ over a 60-day period broken down by opioid and
non-opioid containing analgesics
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Figure 2. Over half of the sample population never received an analgesic that did not contain an
opioid.
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Figure 3. Analgesics given upon arrival to the unit.
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Figure 4. Average pain scores for the first ten pain assessments while on the unit compared with
the average pain scores when an analgesic was administered.
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Reliance on Opioids

Only opioid-containing analgesics used
for pain

45%
n=28

55%
n=34

Non-opioid analgesic given at least
once for pain

Figure 5. Over half of the sample population never received an analgesic that did not contain an
opioid.

Analgesic Therapy

26%
N=165

33%
N=206

Opioid-only
Multimodal
Non-opioid only

41%
N=256

Figure 6. Breakdown of analgesic therapy used for treating 627 patients for pain on the unit over
a 60-day period.
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Appendix B
PRISMA Flow Diagram of Systematic Search

Adapted from “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA
statement,” by D. Moher, A. Liberati, J. Tetzlaff, D. Altman, and PRISMA Group. Copyright
2009 by PLoS Medicine.
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Appendix C
Table of Evidence
Author (Year)
Purpose
Ashfar (2015)
Determine
benefits and
harms of use of
NSAIDs and
non-opioids to
treat renal colic
due to kidney
stones

Design (N)

Inclusion
Criteria
RCTs and
> 16 years
Quasiwith acute
experimental onset pain
RCTs
related to
(N = 3)
kidney stones
(<48 hours)

Baily (2013)
Beneficial and
harm of
combination
acetaminophen
and ibuprofen
for pain after
removal of
wisdom teeth

Doubleblind RCTs
(N = 2)

Intervention vs
Comparison
Combination
therapy to
Monotherapy

Results
Efficacy:
o

Adverse Events:
o

All ages;
removal of
wisdom teeth;
report of
moderate to
severe pain

2 studies found NSAID +
antispasmodic (N = 153) produced a
decrease in VAS score than NSAID
alone (N = 157) (Mean Difference 1.99 [-2.58, -1.40]; p < 0.00001)

Acetaminophen
+ Ibuprofen
to
Ibuprofen or
Acetaminophen
alone

1 study of found NSAID +
Desmopressin (N = 22) produced less
adverse events than Desmopressin
alone (N = 20) (RR 0.14 [0.0, 0.54]; pvalue not reported)

Efficacy:
o

o

o

1 study found 50% or greater pain
reduction significantly more for the
multimodal group (N = 67) than the
individual group (N = 103) (RR 1.77
[1.32, 2.39]; p = 0.0002);
1 study found 50% or greater pain
reduction over 2 hours significantly
more for the multimodal group (N =
67) than the individual group (N = 103)
(RR 1.29 [0.91, 1.85]; p = 0.15)
2 studies found rescue medication for
pain relief was required more often in
the individual group (N = 251) than the
multimodal group (N = 216) (RR 1.60
[1.36, 1.88]; p < 0.00001)

Conclusion
NSAIDs are
effective in pain
management of
renal colic due to
kidney stones;
addition of
antispasmodic to
NSAIDs did reduce
pain

Combination of
Acetaminophen
and Ibuprofen
provided better
relief for pain
related to wisdom
teeth extraction
compared to either
drug alone.
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Double(2012)
blind RCTs
Efficacy,
(N = 2)
tolerability, and
safety of
combination
therapy for
neuropathic
pain

≥ 18 years old
with
neuropathic
pain

Derry (2013)
Determine
efficacy and
adverse effects
of ibuprofen
with
oxycodone for
moderate to
severe
postoperative
pain

> 15 years old
with
established
moderate to
severe pain
(ex. VAS
score > 30)

Doubleblind RCTs
(N = 2)
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Anticonvulsant + Efficacy:
opioid compared o 2 studies found good/moderate pain
relief for Anticonvulsant + Opioid (N =
to anticonvulsant
210) compared to anticonvulsant alone
alone
(N = 213) (RR 1.30 [1.04, 1.161]; p =
0.02)

Adverse Events:
o

Ibuprofen +
Oxycodone
to
Ibuprofen or
Oxycodone
alone

2 studies found participants dropped
out due to adverse events at a higher
rate with anticonvulsant + opioid (N =
216) than anticonvulsant alone (N =
217) (RR 2.76 [1.47, 5.21]; p = 0.002)

Efficacy:
o

o

o

o

2 studies found 50% or greater pain
reduction more with Ibuprofen 400mg
+ Oxycodone 5mg (N = 356) than
Ibuprofen 400mg alone (N = 361) (RR
1.15 [1.00, 1.31]; p = 0.016)
2 studies found 50% or greater pain
reduction more with Ibuprofen 400mg
+ Oxycodone 5mg (N = 356) than
Oxycodone 5mg alone (N = 115) (RR
2.46 [1.75, 3.46]; p < 0.00001)
2 studies found less need for rescue
medication within 6 hours with
Ibuprofen 400mg + Oxycodone 5mg
(N = 356) than Ibuprofen 400mg alone
(N = 361) (RR 0.83 [0.72, 0.97]; p =
0.016)
2 studies found less need for rescue
medication within 6 hours with
Ibuprofen 400mg + Oxycodone 5mg
(N = 356) than Oxycodone 5mg alone
(N = 115) (RR 0.53 [0.46, 0.72]; p <
0.00001)

Adverse Events: no differences

Multimodal therapy
is better for
neuropathic pain
than monotherapy
but is associated
with greater
adverse events
when combining
opioid to
anticonvulsant.
The combination of
Ibuprofen and
Oxycodone
produced greater
analgesia and less
chance of needing
additional analgesia
within 6 hours
without increasing
adverse events
compared to either
drug alone.
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Derry (2013a)
Determine
efficacy and
adverse events
for ibuprofen
with
acetaminophen
for adults with
acute
postoperative
pain compared
to ibuprofen
alone.

Doubleblind RCTs
(N = 2)

Derry (2016)
Determine
efficacy and
adverse events
of ibuprofen
with codeine
use on
moderate to
severe
postoperative
pain

Double
blind RCTs
(N=10)

> 15 years old
with moderate
to severe pain
(ex. VAS
score > 30)

Ibuprofen +
Acetaminophen
to
Ibuprofen
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Efficacy:
o

o

2 studies found >50% pain reduction
with Ibuprofen 400mg +
Acetaminophen 1000mg (N = 216)
than Ibuprofen 400mg alone (N = 143)
(RR 1.30 [1.10, 1.55]; p = 0.0028)
2 studies found less need for rescue
medication with Ibuprofen 400mg +
Acetaminophen 1000mg (N = 216)
than Ibuprofen 400mg alone (N = 143)
(RR 0.57 [0.42, 0.77]; p = 0.00026)

The combination of
Ibuprofen with
Acetaminophen is
produces better and
longer analgesia
and less adverse
events than
Ibuprofen alone.

Adverse Events:
o

> 15 years old
with moderate
to severe pain
(ex. VAS
score > 30)
resulting from
surgery

Acetaminophen
+ Codeine
to
Acetaminophen

2 studies demonstrated fewer adverse
events with Ibuprofen 400mg +
Acetaminophen 1000mg (N = 216)
than Ibuprofen 400mg alone (N = 143)
(RR 0.81 [0.66, 0.99]; p = 0.038)

Efficacy:
o

o

o

4 studies found >50% pain reduction
more with Acetaminophen 8001000mg + Codeine 60mg (N = 153)
than Acetaminophen 800-1000mg
alone (N = 121) (RR 1.31 [1.06, 1.62];
p = 0.014)
10 studies found >50% pain reduction
with Acetaminophen 600-650 mg +
Codeine 60 mg (N = 309) than
Acetaminophen 600-650 mg alone (N
= 313) (RR 1.30 [1.11, 1.52]; p =
0.0013)
2 studies found need for rescue
medication less often with
Acetaminophen 800-1000 mg +
Codeine 60 mg (N = 64) than
Acetaminophen 800-1000 mg alone (N
= 63) (RR 0.61 [0.41, 0.89]; p = 0.011)

Adding codeine to
Acetaminophen
results in greater
and longer
analgesia without
increasing adverse
events compared to
Acetaminophen
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o

Moore (2015)
Determine
efficacy of oral
analgesics for
acute pain of at
least moderate
intensity after
surgery

Doubleblind RCTs
(N = 161)

≥ 15 years old
with moderate
to severe
postoperative
pain

Several single
agents and
combination
therapies
compared as a
group

7 studies found need for rescue
medication significantly was less with
Acetaminophen 600-650 mg + Codeine
60 mg (N = 216) than Acetaminophen
600-650 mg alone (N = 220) (RR 0.75
[0.64, 0.88]; p = 0.00037)

Adverse Events: no differences
Efficacy:
•

o

o
o

o

o
o
o
o

NNT for ≥ 50% pain relief over 4-6
hours
Acetaminophen 650mg (19 studies; N
= 1886) NNT is 4.6 (3.9 to 5.5) and
Acetaminophen 1000mg (28 studies; N
= 3232) NNT 3.6 (3.2 to 4.1)
Codeine 60mg (17 studies; N = 1413)
NNT is 3.9 (3.3 to 4.7)
Acetaminophen 650mg/Codeine 60mg
(17 studies; N = 1413) NNT is 3.9 (3.3
to 4.7) and Acetaminophen
1000mg/Codeine 60mg (3 studies; N =
192) NNT is 2.2 (1.8 to 2.9)
Ibuprofen 400mg (51 studies; N =
5604) NNT is 2.1 (1.9 to 2.3) and
Ibuprofen 600mg (3 studies; N = 203)
NNT is 2.7 (2.0 to 4.2)
Ibuprofen 400mg/Codeine 26-60mg (4
studies; N = 443) NNT is 2.2 (1.8 to
2.6)
Ibuprofen 400mg/Acetaminophen
1000mg (3 studies; N = 543) NNT is
1.5 (1.4 to 1.7)
Ibuprofen 400mg/Oxycodone 5mg (3
studies; N = 603) NNT is 2.3 (2.0 to
2.8)
Oxycodone 15mg (3 studies; N = 228)
NNT is 4.6 (2.9 to 11)

Oral analgesics
produced good
analgesia;
combining two
drugs resulted in
good/long-lasting
analgesia
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o
o
•
o
o
o
o
o
o
o
o

Ramiro (2011)
Determine
benefits and
safety of
combination
therapy for
inflammatory
arthritis

RCTs and
≥18 years with
Quasiinflammatory
randomized arthritis
controlled
clinical trials
(N=18)

At least 2 drugs:
Acetaminophen,
Opioids,
NSAIDs, and
Neuromodulators
to monotherapy
with one of the
drugs

Tramadol 150mg (5 studies; N = 371)
NNT is 2.4 (2.0 to 3.1)
Tramadol 75mg/Acetaminophen
650mg (5 studies; N = 659) NNT is 2.9
(2.5 to 3.5)
Mean time needed to remedication
(statistical details not provided in
article)
Acetaminophen 650mg: 3.5 hours and
Acetaminophen 1000mg: 4 hours
Codeine 60mg: 3 hours
Acetaminophen 650mg/Codeine 60mg:
4 hours
Acetaminophen 1000mg/Codeine
60mg: 5 hours
Ibuprofen 400mg: 6 hours
Ibuprofen 400mg/Acetaminophen
1000mg: 8.5 hours
Acetaminophen 1000mg/Oxycodone
10mg: 8.5 hours
Acetaminophen 650mg/Oxycodone
10mg: 9.5 hours

Efficacy:
o
o
o

2 studies found combination therapy
reduces pain better compared to
monotherapy;
1 study found high dose NSAID was
significantly better than low dose
combination therapy
15 studies found no difference

Adverse Events:
o

1 study found monotherapy had
significantly more study withdrawals
compared to combination therapy; 7
studies found no difference

Evidence is limited
to conclude
combination
therapy is better for
inflammatory
arthritis pain than
monotherapy
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o

Toms (2009)
Double
Determine
blind RCTs
efficacy and
(N = 14)
adverse events
of
Acetaminophen
with codeine
for acute
postoperative
pain compared
to
acetaminophen
alone

> 15 years old
with moderate
to severe pain
(ex. VAS
score > 30)
resulting from
surgery

Acetaminophen
+ Codeine
to
Acetaminophen

1 study found combination therapy had
more adverse events than
monotherapy; 9 studies found no
difference

Efficacy:
o

o

•

•

•

4 studies demonstrated >50% pain
reduction more with + Acetaminophen
800-1000mg + Codeine 60mg (N =
153) than Acetaminophen 800-1000mg
alone (N = 121) (RR 1.31 [1.06, 1.62];
p = 0.014)
10 studies found >50% pain reduction
with Acetaminophen 600-650 mg +
Codeine 60 mg (N = 309) than
Acetaminophen 600-650 mg alone (N
= 313) (RR 1.30 [1.11, 1.52]; p =
0.0013)
2 studies demonstrated need for rescue
medication less often with
Acetaminophen 800-1000 mg +
Codeine 60 mg (N = 64) than
Acetaminophen 800-1000 mg alone (N
= 63) (RR 0.61 [0.41, 0.89]; p = 0.011)
7 studies found need for rescue
medication was less with
Acetaminophen 600-650 mg + Codeine
60 mg (N = 216) than Acetaminophen
600-650 mg alone (N = 220) (RR 0.75
[0.64, 0.88]; p = 0.00037)
Adverse Events: no difference

Adding Codeine to
Acetaminophen
results in greater
and longer
analgesia without
increasing adverse
events compared to
Acetaminophen
alone
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Appendix D
PARiHS Continua of Dimensions

Adapted from “Enabling the implementation of evidence based practice: a conceptual framework,”
by A. Kitson, G. Harvey, and B. McCormack. Copyright 1998 by Quality and Safety in Health
Care.
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Kotter’s Eight Step Change Model

Adapted from “Kotter’s 8-Step Process”, by J. Kotter. Copyright 2017 by Kotter International
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Appendix F
Burke-Litwin Causal Model

Adapted from “A Causal Model of Organizational Performance and Change,” by W. W. Burke
and G. H. Litwin, 1992, Journal of Management, 18, 528.
Management Association.

Copyright 1992 by Southern
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Appendix G
SWOT Analysis of the OBS Unit
Strengths
Weaknesses
• Closed-unit: Staff does not float
• Short average patient length of stay
between units; thus, staff on the OBS
(18hrs); finding a correct pain
unit are consistent
management regimen takes time
• Only one provider group (ECS)
• Current EHR analgesic orders limit
consistently admits patients to the OBS
which analgesic can be given based on
unit
patient’s pain rating and description
• Inpatient pharmacy has a variety of
• Patients in pain is caused by a variety
analgesics on formulary
of reasons; it will be difficult to create
a generic protocol
• Part of SH, which is a top 15 health
care system that promotes care
• New EHR (Epic) being implemented in
improvement initiatives
November 2017; staff preoccupied
learning new system
• Motivated leaders, management, and
staff
that
support
process
improvements
• Low staff turnover
Opportunities
Threats
• Public attention on the opioid crisis;
• Pain management related questions on
SH is prime to champion innovative
patient surveys that are tied to
opioid reduction campaigns
reimbursement
• Decreased
ED
visits
and
• Patients unaccepting of decreased
hospitalizations of people with opioid
emphasis on opioid use
misuse and overdose by preventing
• Staff that does not “buy-in” to the
future opioid dependence
practice change
• Enhance quality of care by integrating
evidence-based care
• Decrease unit’s contribution to the
opioid crisis
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Appendix J
Proposal for Order Set Modification
To: Subject Matter Experts
From: Katie Ellens, BSN, RN
SBAR: Making the case to change the indication for acetaminophen and ibuprofen on the
Observation Unit Order Set
Situation:
1 in 3 patients receive exclusively opioids for the treatment of pain on the Observation unit
Background:
Evidence tells us opioids are modestly better than placebo at treating pain and no better than an NSAID
(Kalso, Edwards, Moore, & McQuay, 2004). Yet, we continue to use opioids for moderate to severe
pain while limiting the use of acetaminophen and ibuprofen. This way of thinking parallels the World
Health Organization (WHO) Pain Ladder. The WHO pain ladder was created in 1986 as a reference to
clinicians on how to treat cancer pain (Teater, 2014). Many providers still reference this framework
today to guide effective treatment of pain.
Unfortunately,
however,
these
recommendations were based on expert
opinion, not on evidence (Vargas. Instead,
evidence shows us that a multimodal
approach (a synergistic method using 2 or
more analgesics with different mechanisms of
action) to treating pain is significantly more
effective at achieving a ≥50% reduction in pain
and increasing time to remedication for pain
(Bailey et al., 2013; Derry, Derry, & Moore,
2013; Derry et al., 2013a; Gaskell et al., 2009;
Toms et al., 2009).
Consider the number needed to treat (NNT) statistical measure when comparing the effectiveness of
pain medications (NNT = how many people must be treated to produce a ≥50% reduction in pain in 1
person) (Moore, Derry, McQuay, & Wiffen, 201):
Single Agent Treatment
Multimodal Treatment
• Oxycodone 15mg NNT is 4.6
• Oxycodone 10mg + Acetaminophen
650mg NNT is 2.7
• Acetaminophen 650mg NNT is 4.6
• Oxycodone 5mg + Ibuprofen 400mg NNT
• Acetaminophen 1000mg NNT is 3.6
is 2.3
• Ibuprofen 600mg NNT is 2.7
• Ibuprofen 400mg + Acetaminophen
1000mg NNT is 1.5
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Evidence demonstrates multimodal treatment produces more effective pain management while
reducing the dose of oxycodone required for better analgesia. In fact, the most effective combination
is ibuprofen + acetaminophen. Despite evidence demonstrating opioids are not as effective as
commonly believed, we do know, that opioids have a strong psychotherapeutic effect that help relieve
the emotional distress of pain (Teater, 2014). This makes opioids useful for treating acute pain.
Assessment:
Although evidence clearly shows us that coadministering acetaminophen or an NSAID
with an opioid produces more effective pain
relief than when administering an opioid in
isolation, our orders sets are preventing this
from happening. The indication for ibuprofen
and acetaminophen are currently for “mild
pain (1-3) or per patient description”. The RN
could conceivably give ibuprofen for
acetaminophen or ibuprofen for a pain score
of any number as long as the patient describes
the pain as mild. However, the order would
restrict the RN from administering ibuprofen
or acetaminophen WITH an opioid (ie oxycodone) because oxycodone is generally ordered for
moderate to severe pain. If the RN were to ignore the indications and administer evidence-based pain
management, the RN would be practicing outside of his or her scope of practice according to the Joint
Commission. Interestingly, the current Observation Order set features pain medications orders in a
similar fashion to the WHO pain ladder.

Recommendation:
Change the indication for acetaminophen and ibuprofen from “mild pain (1-3) or patient
description” to “for pain (1-10), may co-administer with an opioid for moderate to severe pain
(4-10)”. This indication allows for acetaminophen and ibuprofen to be used as a multimodal
approach for all pain levels. It gives clear direction on when it is appropriate, and when it can be
co-administered with an opioid. This indication has been used in another hospital organization in
order to promote more multimodal pain management.
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Appendix K
Sample Pre/Post Survey
1. True or False: Opioids are the best treatment for pain
2. Which of the following pain management options has been found to produce the best pain
relief:
a. Oxycodone 15mg
b. Ibuprofen 800mg
c. Oxycodone 5mg/Ibuprofen 400mg
d. Acetaminophen 1000mg/Ibuprofen 400mg
3. True or False: Opioids, acetaminophen, and NSAIDs have different mechanisms of action
that results in pain relief
4. On the Observation unit, how many patients receive ONLY opioids to manage their pain
while on the unit?
a. 1 in 3 patients
b. 1 in 4 patients
c. 1 in 5 patients
d. 1 in 6 patients
5. True or false: When more than one analgesic is used to treat pain, the same level of pain
relief may be achieved with a lower dose of each analgesic.

Question 5) Wells, N., Pasero, C., & McCaffery, M. (2008). Improving the quality of care through
pain assessment and management. In R. G. Hughes (Ed.), Patient safety and quality: An evidencebased handbook for nurses. Rockville, MD: Agency for Healthcare Research and Quality.
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Timeline for Implementation
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GVSU IRB Determination
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Organization IRB Determination
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Appendix O
Budget for DNP Project
Initial Cost: Evidence-based Pain Management
Transitioning focus from opioids to multimodal
analgesia for pain management
Revenue
Project Manager Time (in-kind donation) 2,820.00
Team Member Time:
Statistician (in-kind donation)
100.00
Presidential Research Grant: White Paper for
organization, educational flyers, binder to leave on
unit for next step
114.80
Cost mitigation (Prevention of 1 hospitalization and
1 ED visit related to opioid overdose per year)
3.8-day Hospitalization (1-year period) 29,497.00
Emergency department visit (1-year period)
3,640.00
TOTAL INCOME
36,171.80
Expenses
Project Manager Time (in-kind donation)
Statistician (in-kind donation)
Color-printed Educational Flyers
Professionally Printed White Paper
Binder with steps for sustainability
Team Member Time:
Registered Nurses (extra time spent in staff
meeting to be educated on pilot project)
Educate NPs and PAs (time spent reading
education on pilot project)
Educate Physicians (time spent reading education
on pilot project)
Pharmacist Consultation (one-time cost
occurrence)
Clinical Nurse Specialist Consultation (one-time cost
occurrence)
Pharmacy Technician generating weekly report (8time occurrence)
TOTAL EXPENSES
OPERATING INCOME

2,820.00
100.00
82.80
25.00
7.00

225.00
490.00
655.00
60.00
96.00
128.00
4,688.80
31,483.00
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Letter of Support for Organization Advisor
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Structured Abstract
Background: Pain is the most common reason people seek healthcare. Recent opioid-centric
practice has led to a 400% increase in opioid prescriptions without reducing the prevalence or
intensity of pain. Consequently, an opioid crisis has ensued with devastating effects.
Objectives: To provide pain relief while reducing opioid use with evidence-based multimodal
analgesia in an Emergency Department Observation Unit.
Methods: Quality improvement project to establish multimodal analgesia as the standard of care.
Data on analgesic use and pain levels were gathered pre-/post-implementation and compared.
Results: Multimodal analgesia delivery increased (p < .0001) and pain level scores (p = 0.022)
declined. Opioid consumption among high opioid utilizers (p < 0.0001) were decreased postimplementation. Reliance on opioid analgesics to treat pain were reduced (p < .0001). However,
patient satisfaction regarding pain control (p = 0.0018) declined.
Conclusions: Multimodal analgesia can provide effective pain relief in certain settings while
reducing opioid-reliance and consumption.
Implications: Multimodal analgesia is a simple technique that could reduce the perpetuation of
the opioid crisis in certain settings. Further study is needed in multiple settings.
Keywords: Multimodal Analgesia, Pain Management, Acute Nociceptive Pain, Opioid Crisis
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Introduction
Pain is the most common reason people seek healthcare in the United States (US)
(National Institutes of Health, 2013). Consequently, healthcare providers are under enormous
pressure to provide pain relief. Initiatives, such as the American Pain Society “Pain as the fifth
vital sign” (1996) and the Joint Commission Pain Management Standards (2001), set the stage
for aggressive pain management. Opioids were increasingly utilized to address pain complaints
as evidenced by the 400% increase in opioid prescriptions since 1999 (Paulozzi, Jones, Mack, &
Rudd, 2011). Despite increased reliance on opioids for pain over the two decades, self-reported
pain prevalence remains unchanged and the intensity of reported pain appears to be increasing
(Centers for Disease Control and Prevention, CDC, 2016; Chang, Daubresse, Kruszewski, &
Alexander, 2014).
Increased use of opioids did not have the intended effect on pain. Instead, it has resulted
in devastating consequences termed the “opioid crisis”. Research has shown opioid use for acute
pain is associated with long-term opioid use (Shah, Hayes, & Martin, 2017). Nearly 25% of
individuals who used opioids long-term struggle with addition (Boscarino et al., 2010). In 2011,
approximately 1.5 million people were treated in emergency departments (EDs) for prescription
drug misuse, three-times the rate in 2004 (Substance Abuse and Mental Health Services
Administration, SAMHSA, 2013). Additionally, there has been an annual increase in opioidrelated deaths, a 300% increase in reported opioid abuse, and a fourfold increase in substance
abuse related admissions (SAMHSA, 2010).
The popular view that opioids are the strongest painkiller available persists; however, this
notion is not supported by evidence (Teeter, 2014). Opioids are modestly effective at relieving
pain compared to a placebo and no more effective than nonsteroidal anti-inflammatory drugs
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(NSAIDs) (Kalso, Edwards, Moore, & McQuay, 2004). Notwithstanding evidence, the belief
remains that opioids should be the standard of care for severe pain. A majority of family
physicians believe opioids are the standard of care for acute pain (66%) and chronic pain (56%);
and 56% indicate patient expectations factor into their decision to prescribe opioids (Onishi et
al., 2017). Although lacking evidence to presume opioids should be the standard of care for pain,
notably opioids exert a psychotherapeutic effect which may help relieve the emotional distress of
pain (Teater, 2014). As a result, opioids remain useful, particularly for acute pain. However, a
more balanced approach may be required to address the opioid crisis.
An alternative to overreliance on opioids for pain is multimodal analgesia. Multimodal
analgesia combines two or more analgesics with different mechanisms of action to produce a
synergistic effect on pain relief (Young & Buvanendran, 2012). The premise of multimodal
analgesia is alteration in the pain signal along multiple sites of the pain pathway within the
peripheral and central nervous system, leading to additive pain relief, while permitting smaller
doses of each analgesic (White, 2017). Multimodal analgesia has been recommended by several
professional organizations (Cantrill et al., 2012; American Society of Anesthesiologists Task
Force, 2012; The Joint Commission, 2012; Thorson et al., 2014). Multimodal analgesia with
opioids, acetaminophen, and NSAIDS is an evidence-based approach that provided more
effective and efficient acute nociceptive pain relief with no increased adverse effects when
compared to single agent therapy (Baily et al., 2013; Derry, S., Derry, C. J., & Moore, 2013;
Derry, Derry, & Moore, 2013a; Derry, S., Karlin, S. M., & Moore, 2015; Toms, Derry, Moore, &
McQuay, 2009). Furthermore, multimodal analgesia demonstrated opioid-sparing effect (Moore,
Derry, McQuay, & Wiffen, 2015).
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Evidence supports multimodal analgesia for pain relief, yet uptake of this practice is not
occurring and the opioid crisis persists. Opioid prescriptions following ambulatory pain visits
doubled from 2000 to 2010, while non-opioid analgesic prescriptions declined 25% (Daubresse
et al., 2013). Furthermore, 236 million opioid prescriptions were dispensed in 2016 – enough for
nearly every adult in the US (Pezalla, Rosen, Erensen, Haddox, & Mayne, 2017). Acute care
settings demonstrate similar opioid-centric practices. Pharmacological pain treatment in EDs
increased 25% from 2000 to 2010 while non-opioid analgesia declined 25% (Chang, et al.,
2014). These trends indicate pain is treated aggressively with opioids, while non-opioid analgesia
is underutilized.
Organizational Assessment
An assessment of a hospital ED Observation unit (OBU) located in the Midwest
identified similar pain management trends. The OBU serves patients experiencing acute
nociceptive pain, with the most common diagnoses being renal colic/nephrolithiasis, back pain,
cellulitis, musculoskeletal injuries, and dental infections.
The Burke-Litwin Causal Model identified and defined organizational dimensions
causally linked that could affect change on the OBU (Burke & Litwin, 1992). Strengths,
weaknesses, opportunities, and threats were also analyzed to understand the context of the OBU
(Fallon, 2017). Three key factors were identified. First, the OBU changed EHRs three weeks
prior to the implementation of the practice change. Second, the indication for acetaminophen and
ibuprofen were preprogrammed in the EHR and limited use of non-opioids to mild pain with a
pain self-assessment score of 1 to 3 (on a scale of 0-10). Third, beliefs of staff and patients
regarding opioids may have prevented acceptance of non-opioids and decreased patient
satisfaction if used.
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The Promoting Action on Research in Health Sciences (PARiHS) framework provided
insight into overreliance on opioids. The PARiHS framework claims successful implementation
of research into practice is a function of evidence, context, and facilitation (Kitson, Harvey, &
McCormack, 1998). Often, context and/or facilitation are not addressed and the change fails.
Despite significant evidence and support by professional organizations, context and facilitation
have likely been ignored, resulting in slow or incomplete acceptance of multimodal analgesia use
(White, 2017). Thus, to alter practice from opioid-centric to multimodal analgesia, the context
and facilitation surrounding the practice change must be tailored to the setting in which the
change needs to occur.
The assessment revealed heavy reliance on opioids for pain, with the majority (76%) of
analgesics dispensed being opioids. Oxycodone was dispensed more than acetaminophen,
ibuprofen, and ketorolac combined with 1 in 3 patients receiving only opioids. An electronic
health record (EHR) review found non-opioid analgesics were prescribed for 76% (n = 47) of
patients; and of those with a non-opioid prescribed, 40% (n = 19) of patients were not
administered a non-opioid and received only opioid-containing analgesics. As a result of
administration policy and prescribing practice, non-opioids were underutilized on the OBU.
Providing pain relief is an important consideration for healthcare providers, and current
opioid-centric practices are ineffective. Alternatively, multimodal analgesia offers a balanced
approach, which produces pain relief while having an opioid-sparing effect. Guided by the
PARiHS framework, this project implemented multimodal analgesia practice as the standard of
care on an OBU when opioids were administered. Results of this project answered the following
clinical question: Does multimodal analgesia, when practiced routinely, provide effective pain
relief while simultaneously reducing unnecessary opioid use?
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Methods
The design of the project was “pre-” “post-” implementation comparison, each containing
a 60-day interval. To evaluate the impact of the practice change, pre-/post-implementation
automated medication dispensing system (AMDS) data for commonly used analgesics were
examined. Primary outcomes were pain relief and opioid use. To examine multimodal analgesia
practices impact on primary outcomes, percentage of patients receiving different analgesic
combinations (only opioids, multimodal analgesia, and only acetaminophen or NSAIDs) were
examined. The aim of the practice change was to increase multimodal analgesia and decrease the
percentage of patients receiving only opioids by 50%.
Data were collected from the AMDS on patients dispensed an analgesic; and examined to
determine the combination of analgesics dispensed. Pain relief was measured using the numeric
pain rating scale (NPRS) scores and patient satisfaction with pain control. The NPRS is an 11point scale on which patients’ self-rate pain sensation on a continuum with 0 being no pain and
10 being the worst pain imaginable. The first 10 NPRS scores following OBU admission were
extracted during an EHR chart review on every 10th patient identified from the AMDS data.
Patient satisfaction data were from monthly Press Ganey surveys provided 48 hours to 6 weeks
post-discharge on the question “how well your pain was controlled”. Opioid use was defined as
both opioid reliance and opioid consumption. Opioid reliance was measured as the ratio of
opioid to non-opioid analgesics dispensed in AMDS data. Opioid consumption was measured by
morphine equivalent dose (MED) received from the AMDS data. MED is a common unit that
represents the potency of various opioids. Data were recorded on an Excel spreadsheet for
statistical analysis with the Statistical Analysis System (SAS 10.0). Data were analyzed using
descriptive, chi-square, paired t-tests, and Mann Whitney U test statistics with a p-value of ≤ .05
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representing statistical significance. The project was approved through the university and site
Institutional Review Boards and determined to be a quality improvement project.
Implementation was guided by Kotter’s 8 Step Process for Leading Change (see Figure 1).
Strategies to promote practice change included the following. A 15-minute educational session
for RNs at a staff meeting and a handout supplied to each provider regarding multimodal
analgesia evidence, recommendations from professional organizations, advice on addressing
patient expectations and communicating the benefits of multimodal analgesia, and
encouragement of collaboration among providers and RNs. A culture supportive of change,
included identification of change agents (medical director, charge nurses), provision of weekly
audit and feedback on clinical performance pertaining to pain management practices, and
interviews of staff regarding behavior changes. Change agents promoted the practice change to
staff daily during rounds. To facilitate increased non-opioid utilization, a change to the
prescribed indication for acetaminophen and ibuprofen were sought. This included altering the
acetaminophen and ibuprofen indications to “for all pain severities 1 to 10 on the scale; may coadminister with an opioid for score of 4 to 10”. The lead author served as the facilitator of the
practice change and possessed openness, flexibility, and consistency to modify the strategies
during implementation as needed.
Results
All practice change strategies, except modification to the acetaminophen and ibuprofen
indications in the EHR OBU-specific order set were implemented, due the change in platform
(see Table 1). Overall, 5,608 analgesics were dispensed to 1,240 patients during the pre/postimplementation 60-day intervals. Post-implementation patients received a lower rate of opioidonly treatment and a higher rate of multimodal analgesia (see Figure 2; p < .0001). Median
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comparison of MED opioid consumption pre/post-implementation 60-day intervals were not
different (see Table 2; p = 0.6). Approximately 80% of each group accounted for ≤ 50 MEDs
(see Figure 3); thus, users were divided into two groups: the lowest 80% MED users and the
highest 20% MED users. As shown in Table 3, fewer opioids were consumed among highest
20% MED users post-implementation (p < 0.01); and no differences were found among lowest
80% MED users (p = 0.21). Most importantly, opioid dispensing rates declined postimplementation (p < .0001; see Table 4). Press Ganey® patient satisfaction scores with pain
control were lower (p < 0.01; see Figure 4).
EHR records randomly selected for review are shown in Table 5. The postimplementation patients were older (p= 0.04), yet no differences in MED rates were found
among groups. Twice as many pre-implementation patients received opioid-only treatment but it
did not reach significance (p = 0.07). NPRS scores were lower (see Figure 5; p = 0.02),
indicating pain relief improved. This does not provide insight into why patient satisfaction scores
were lower during this time period.
Discussion
All practice change strategies attempted were considered successful. Alteration to
electronic orders was delayed due to the EHR platform change. A modification request was
submitted to OBU leadership, and is under consideration.
Notably, a 52.4% decrease in opioid-only pain management occurred after project
implemented. Remarkably, a decrease in opioid MED was found among the highest opioid
utilizers. This suggests that multimodal analgesia has the greatest effect on usage when greater
amounts of opioids are required for pain relief. However, it remains unclear if greater MED
usage was due to the length of stay and/or clinical condition of the high utilizer patients. The
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median length of patient stay on the OBU is 18 hours, limiting the evaluation period for the
impact of multimodal analgesia on the opioid consumption. Furthermore, intense acute
nociceptive pain may require the opioid relieving effect on emotional distress, as in a study by
Warren et al. (2017). On the first post-operative day after hernia repair when acute nociceptive
pain was at its greatest, the multimodal analgesia group required significantly less MED than the
group treated with only opioids (Warren et al., 2017). One important strength of this project,
compared to Warren et al. (2017), was our large MED sample size (N = 1240).
Pain relief is not compromised by the increased multimodal practices, (Baily et al., 2013;
Derry, et al., 2013; Derry et al., 2013a; Derry et al., 2015; Moore et al., 2015; Toms et al., 2009).
Opioid dispensing rates decreased and corresponded to the increase in non-opioid dispensing in
this project. As shown, there were a greater proportion of patients receiving multimodal and half
as many receiving only opioids, resulting in lower NPRS scores. This suggests multimodal
analgesia produces better pain relief. Patient satisfaction with pain treatment, alternatively, was
lower. This is not be surprising, as research has shown more opioid prescribing leads to greater
satisfaction (Sites et al., 2018). Patient satisfaction with pain control did appear to fluctuate
throughout the previous 12-months so it is unknown if decreased pain control satisfaction was
incidental or related to the practice change. The low return rate of the satisfaction surveys, as
only 55 of the eligible 597 patients responded to the pain control question during the postimplementation period. Furthermore, decreased staffing during December and January due to
peak flu season is common, and may contribute to satisfaction rates (CDC, 2018). The ongoing
challenge is to provide both effective and satisfactory pain relief, while simultaneously limiting
unnecessary opioid use.
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Future confirmed and pending policy changes may impact this project. As a result of this
project, the organization is reviewing a policy that inadvertently promoted opioid-centric
practices. The organization is also considering altering the generic indication currently used, for
both acetaminophen and ibuprofen system-wide to “for all pain severities (score 1-10/10); may
co-administer with an opioid for moderate to severe pain (score 4-10/10)”. Within a month of
project completion, The Joint Commission visited the organization and project results and
recommendations were acknowledged in a favorable manner to address policy and practice
regarding use of opioids. Furthermore, policy change in June 2018 in this state will require the
organization to access the state automated prescription system prior to provider prescribing
opioids in order to assess patient opioid use history, strengthening the results of this project.
Limitations
Limitations included the following. The design and scope of the project did not capture
additional meaningful data to explain potential differences in pain control satisfaction, length of
stay, diagnosis, and current opioid use. Different patients were compared pre-/postimplementation; thus, there was no way to determine baseline pain control satisfaction level. The
patients may have also been experiencing chronic pain, which may have impacted the patient
satisfaction scores. Furthermore, a greater proportion of patients in the pre-implementation
interval received >200 MED. Because length of stay was not determined, it is difficult to
ascertain whether the decrease in high MED utilizers in the post-implementation group was due
to multimodal practices or length of stay. Diagnosis also contributed; as providers stated they
prescribe based on clinical condition, thus diagnosis was likely influencing prescribing patterns.
Without precise awareness of diagnosis pre/post-implementation, it was difficult to determine
whether clinical conditions influenced outcome. Finally, knowing whether patients are current
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opioid users could alter how results were interpreted. Opioid-naïve patients require a smaller
opioid MED compared to opioid-tolerant patients (Adesoye & Duncan, 2017). Whether a patient
is naïve or tolerant is not assessed on the OBU; thus, could not be extracted from the EHR. To
address these limitations, 60-day intervals to obtain a larger sample size were used, minimizing
impact on the findings.
Although the external environment created an opportunity for the project to succeed, it
may also have served as a limitation through bias. The opioid crisis frequented the news during
the project timeline. In October 2017, the opioid crisis was deemed a public health emergency by
the President of the US (Allen & Kelly, 2017). Because the opioid crisis was poignant, it is
possible providers, RNs, and/or patients had a bias against using opioids which contributed to the
decrease in MED. To adjust for this, education and the feedback reports repeatedly emphasized
the purpose of this practice change was not to withhold opioids when deemed necessary, but
instead to use a variety of analgesics.
Conclusion
Pain is the most prevalent patient complaint in the US (National Institutes of Health,
2013). Dependence on opioids for pain has led to devastating consequences. Researchers found
opioids are more effective and efficient when given in combination with non-opioid analgesics
(Baily et al., 2013; Derry, et al., 2013; Derry et al., 2013a; Derry et al., 2015; Moore et al., 2015;
Toms et al., 2009). A practice change tailored for an OBU established multimodal analgesia as
the standard of care, leading to a significant MED decrease in high opioid utilizers without
sacrificing pain relief. Patient satisfaction, however, decreased. These results were unique to this
setting and are not generalizable. Nevertheless, these results suggest that multimodal analgesia
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could potentially provide effective pain relief in similar settings, while also potentially reducing
the perpetuation of the opioid crisis.
Implications for Practice and Further Study in the Field
Reliance on opioids as the only treatment for pain should be limited. Evidence
demonstrates using a variety of analgesics can decrease dependence on any one medication. This
project revealed that in an OBU, multimodal practices may have reduced the perpetuation of the
opioid crisis by limiting unnecessary opioid use. Further study in multiple settings with acute
nociceptive pain are needed. Future projects should include practice change strategies aimed at
increasing patient satisfaction while implementing multimodal practices and emphasis on
including patients as key stakeholders. Additional pharmacological and non-pharmacological
pain management options should also be considered. The addition of a pharmacist to the team
would be beneficial. Efforts to enable multimodal analgesia as the standard of care in settings
treating patients similar to those of the OBU unit could produce similar results.
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Figure 1. Timeline as guided by Kotter’s 8 Step Process for Leading Change
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Percentage of Patients Receiving Each Analgesic Combination
56.3%

60
50

44.7%

40
29.8%
30

29.2%

26.1%

20

13.9%

10
0
Acetaminophen or NSAID only

Multimodal

Opioid-Only

p =p0.1479
= 0.15

p < .0001
p<

p < .0001

Pre-Implementation

Post-Implementation

.0001
Figure 2. Percentage of patients pre-/post-implementation receiving opioids-only, multimodal
treatment, or Acetaminophen or NSAID only
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MED Distribution
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Figure 3. Distribution (0-50; 51-100; 101-150; and >150) of MED pre-/post-implementation
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Percent of Patients Satisfied with Pain Control
90.00%
80.00%

78.6%
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Pre-Implementation

n = 55

Post-Implementation

n = 39

Figure 4. Percent of patients satisfied with pain control on patient experience satisfaction report
on OBU
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First 10 Pain Assessment Scores
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Tables
Table 1. Practice change strategy outcomes measured, when measured, and result
Strategy
Build a Coalition

Education
• RN staff
meeting
• Educational
handout for
providers
• Educational
flyer for
resource
Modification of
acetaminophen and
ibuprofen order
indication
Audit and feedback

Behavior Change
Review

How measured
Checklist tool
(Charge nurses)
Interview
(Medical
director)
Pre/Post-test
(RNs)
Survey
(Providers)

When measured Result
Every 12hr shift Multimodal analgesia was
discussed at 57.4% of shifts (n = 58
of 101)
November 2017 3 provider emails
– January 2018
1 meeting (December)
Pre/post
education

57% (n = 19 of 33) RNs attended
Pre-test: 67% mean score (SD 20)
Post-test: 100% mean score (SD 0)

November 15 –
December 1

83.3% (n = 10 of 12) PAs/NPs
received handout
46.6% (n = 7 of 15) physicians
received handout
100% (n = 9) surveyed agreed with
project

Weekly from
December 1,
2017 – January
29, 2018
February 2018

Weekly opioid-only therapy was
consistently 50% lower than preimplementation data

Not completed

Automated
medication
dispensing
system report
Interview

RNs themes:
• “Once I explained
multimodal to patients, most
of them agreed”
• “I changed my practices
after learning about
multimodal analgesia”
• “Multimodal seemed to help
some patients more than
others”
Provider themes:
• “I always prescribe a variety
of pain medications”
• “I treat patients based on
their clinical presentation”
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Table 2. Opioid consumption outcome with all patients pre/post-implementation

Median MED

Pre-implementation
patients receiving an opioid:
N = 464
Median (IQR)
[Range]
20 (35)
[2 – 527.5]

Post-implementation
patients receiving an opioid:
N = 404
Median (IQR)
[Range]
20 (30)
[1 – 392]

p-value
0.6
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Table 3. Pre-/post-implementation high utilizers (top 20%) and low utilizers (bottom 80%) and
p-values
20% high utilizers
PrePostimplementation implementation
N = 93
N = 81
N (%)
N (%)

p-value

80% low utilizers
PrePostimplementation implementation
N = 372
N = 323
N (%)
N (%)
p-value

Multimodal
Analgesia

46 (48.4%)

72 (88.9%)

<.0001

232 (62.4%)

249 (77.1%)

<.0001

Opioidonly
Analgesia

49 (51.6%)

9 (11.1%)

<.0001

139 (37.3%)

74 (22.9%)

<.0001

Mean ± SD
[Range]
118.71 ± 85.34
[53 – 527.5]

Mean ± SD
[Range]
91.54 ± 60.35
[45 – 392]

Mean ± SD
[Range]
19.15 ± 13.25
[2 – 53.5]

Mean ± SD
[Range]
18.37 ± 11.62
[1 – 46]

Average
MED

0.01

0.21
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Table 4. Ratio of opioids to non-opioids dispensed
Dispenses

Opioid
Non-Opioid

Pre-implementation:
N = 2877
N (%)
2184 (75.9%)
693 (24.1%)

Post-implementation:
N = 2731
N (%)
1745 (63.9%)
986 (36.1%)

p-value
< .0001
< .0001
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Table 5. Pain self-assessment NPRS scores from EHR review

Multimodal Analgesia used

Pre-implementation
N = 62
n (%)
28 (45.2%)

Post-implementation
N = 58
n (%)
31 (53.5%)

p-value
0.36

Opioid-only Analgesia used

17 (27.4%)

8 (13.8%)

0.07

Acetaminophen or NSAID only

17 (27.4%)

19 (32.8%)

0.52

Non-Opioid was Ordered (Yes)

47 (75.8%)

51 (87.9%)

0.10

If Ordered, Non-Opioid was Used (Yes)

28 (60.9%)

39 (76.5%)

0.08

Median [IQR]
[Range]
15 [30]
[0 – 135]
Mean ± SD
[Range]
51.27 ± 19.76
[18 – 99]
3.00 ± 1.91
[0 – 10]

Median [IQR]
[Range]
10 [26]
[0 – 168.5]
Mean ± SD
[Range]
58.81 ± 19.13
[18 – 93]
4.21 ± 2.27
[0 – 10]

MED

Age (years)
Average NPRS Score

0.5

0.04
.002
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Objectives for Presentation
1. Review the problem.
2. Review the evidence.
3. Present the plan.
4. Review the results.
5. Discuss next steps.
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The Problem
• Pain is the most prevalent problem in healthcare (National Institutes of Health, 2013)
• Opioids are increasingly relied upon (Paulozzi, Jones, Mack, & Rudd, 2011)
• Yet, no improvement in pain (CDC, 2016; Chang et al., 2014)
• Opioid use for acute pain is associated with long-term opioid use

(Shah,

Hayes, & Martin, 2017)

• Opioid-centric practices not evidence-based
• Opioids are modestly better than placebo (Kalso, Edwards, Moore, & McQuay, 2004)
• No better than NSAIDs (Kalso et al., 2004)
• Opioids have strong psychotherapeutic effect (Teater, 2014)
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Significance
• Since 1999,
• Opioid prescriptions have quadrupled (Chang et al., 2014)
• A 300% increase in reported opioid abuse (Substance Abuse and Mental
Health Services Administration, SAMHSA, 2010)

• Substance abuse admissions increased 4x (SAMHSA, 2010)
• Annual opioid-related deaths in Michigan have tripled during
this time (Trust for America's Health, 2017)

We must treat pain but be aware of the Opioid Crisis
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Clinical Question
For people experiencing pain, would using evidence-based pain
management provide effective pain relief and reduce opioid use
compared to opioid-centric pain management?
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Literature
Review
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Efforts to Decrease Reliance on Opioids –
Current Recommendations
• American College of Emergency Physicians (Cantril et al., 2012)
• American Society Anesthesiologists Task Force on Acute Pain Management
(American Society of Anesthesiologists Task Force, 2012)

• The Joint Commission (The Joint Commission, 2012)
• Institute for Clinical Systems Improvement
(Thorson et al., 2014)

Multimodal Analgesia
Combining ≥2 analgesics with different
mechanisms of action to produce synergistic
pain relief
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What does the Literature say?
• Question: Multimodal is recommended by many
organizations – is it evidence-based?
• Aims:
• Compare Multimodal to single agent
• better pain management?
• reduce opioid use?
• safe?
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Literature Review
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Literature Review
• Better Pain Management = Yes
• Achieved pain reduction significantly more often
• Longer time between remedication
• Combinations
• Oxycodone & Ibuprofen
• Oxycodone & Acetaminophen
• Codeine & Acetaminophen
• Acetaminophen & Ibuprofen

Bailey et al., 2013; Derry, Derry, & Moore, 2013; Derry, Derry, & Moore, 2013; Derry, Karlin, & Moore, 2015; Toms, Derry, Moore, & McQuay, 2009
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Literature Review
• Reduced opioid use = Yes
• NNT
• Single agent:
• Oxycodone 15mg NNT is 4.6
• Multimodal:
• Oxycodone 10mg + Acetaminophen 650mg NNT is 2.7
• Oxycodone 5mg + Ibuprofen 400mg NNT is 2.3
• Adverse Events
• No differences found between multimodal and single agent pain
management
Moore, Derry, McQuay, & Wiffen, 2015
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Organizational
Assessment
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Setting: Midwest hospital ED Observation unit
Most common diagnoses
1. Chest Pain (29%)
2. Kidney Stones (8.4%)
3. ESRD (4.4%)
4. Heart Failure (4.1%)
5. Back Pain (4%)
Others include cellulitis, dental abscess, psychiatric
placement, falls/fractures/weakness (need rehab)
14
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Assessing the Organization
Burke-Litwin Model
• Two distinct dynamics
• Climate
• Culture
• Transformational and Transactional
variables
• External environment is the main
driver of change
Burke & Litwin, 1992
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SWOT Analysis
Strengths
•
•
•
•
•

•

Weaknesses

Closed-unit: Staff does not float between units; thus,
staff on the OBS unit are consistent
Only one provider group (ECS) consistently admits
patients to the OBS unit
Inpatient pharmacy has a variety of analgesics on
formulary
Part of SH, which is a top 15 health care system that
promotes care improvement initiatives
Motivated leaders, management, and staff that
support process improvements
Low staff turnover

“to improve the health of the
communities we serve”

Teamwork

Opportunities
•
•

•
•

•
•
•
•

Provide evidence-based
pain management

Prescriptive pain
medication orders

New EHR November 5, 2017

Threats

Public attention on the opioid crisis; SH is prime to •
champion innovative opioid reduction campaigns
Decreased ED visits and hospitalizations of people •
with opioid misuse and overdose by preventing future
opioid dependence
Enhance quality of care by integrating evidence- •
based care
Decrease unit’s contribution to the opioid crisis

Opioid crisis

Short average patient length of stay (18hrs); finding a
correct pain management regimen takes time
Current EHR analgesic orders limit which analgesic
can be given based on patient’s pain rating and
description
Patients in pain is caused by a variety of reasons; it
will be difficult to create a generic protocol
New EHR (Epic) being implemented in November
2017; staff preoccupied learning new system

Pain management related questions on patient
surveys that are tied to reimbursement
Patients unaccepting of decreased emphasis on
opioid use
Staff that does not “buy-in” to the practice
change

Patients want opioids
Patient satisfaction
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Needs Assessment
• 75% of analgesics used are opioids
• Nearly 1 in 3 (29%) patients received only opioids
• Oxycodone used more than acetaminophen, ibuprofen, and ketorolac

combined
• Non-opioids not ordered for 25% of patients
• When ordered, non-opioids still not given for 40% of patients
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DNP Project Plan
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Project Purpose and Objective
• Establish multimodal analgesia as the standard of care
when opioids are used
• Objective: Decrease percentage of patients receiving only
opioids for pain by 50%

• Evaluate whether multimodal analgesia:
• Provided effective pain relief
• Decreased opioid use
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Type of Project
• Quality Improvement Project
• Seeking to improve the delivery of
care in order to:
• Improve patient experience
• pain relief

• Improve outcomes
• decrease chance of perpetuating opioid
crisis

______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
__

IMPLEMENTION OF EVIDENCE-BASED PAIN MANAGEMENT

123

Slide 21

Participants and Resources
• Participants
• Any patient dispensed an analgesic
• Registered Nurses (RNs)
• Providers: Physicians, Nurse Practitioners (NPs), Physicians
Assistants (PAs)

• Resources
• Time spent educating RNs and providers, creation of educational
handouts, flyers, pre- and post-education tests for RNs, time of
pharmacy technician providing data
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Ethics and Human Subjects Protection
• Deemed Quality Improvement Project

Organization IRB approval
letter available upon request
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Frameworks
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PARiHS Framework
Fits the Opioid Crisis phenomenon

SI = f(E, C, F)
Successful Implementation of a practice
change

Kitson, Harvey & McCormack, 1998

______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
__

IMPLEMENTION OF EVIDENCE-BASED PAIN MANAGEMENT

127

Slide 25

Kotter’s 8 Step Change Model

Kotter, 1996
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Project Details
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Project Design
• Before-and-After Study
Pre-Implementation
Interval
• 60-days
• May 5 – July 4,
2017
• First data
collection
Data:
1. Medication Use
2. Pain Relief

November, 2017:
Implementation begins with
building coalition, education,
and indication change

Post-Implementation
Interval
• 60-days
• December 1, 2017
– January 29, 2018
• Second data
collection
Data:
1. Medication Use
2. Pain Relief
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Project Strategies
Before Second Data Collection

Context

• Build a coalition of change agents
including the charge nurses and
medical director to champion
multimodal analgesia as the new
standard of care
• Daily huddles
• Frequent provider emails

Evidence

• Create and disseminate education
regarding multimodal analgesia
including literature supporting it and
advice on scripting to patients
• RN Staff Meeting
• Educational Handout
• Flyers

• Modify the indication for
acetaminophen and ibuprofen to
Facilitation
expand use for all pain severities
- “For pain 1-10/10, may co-administer
with an opioid for pain 4-10/10”

During Second Data Collection
• Provide weekly audit and feedback
reports for 60-day postintervention interval to evaluate
clinical performance of pain
management practices
-

Context
Facilitation

Daily huddles
Provider emails

After Second Data Collection
• Review RNs and providers
perceptions of behavior change
and effectiveness of multimodal
analgesia practices
-

Evidence
Context
Facilitation

Interviews
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Project Timeline
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Measures

______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
__

IMPLEMENTION OF EVIDENCE-BASED PAIN MANAGEMENT

133

Slide 31

Measuring the Strategies
Strategies

Building a Coalition

How measured
(tool, survey,
variable)

When Measured

Who Measured

Checklist (discuss project at
each shift meeting)

Every shift (twice daily)

Charge Nurses

Interview
(Medical director)

November 2017 – January
2018

DNP Candidate

Education
RN staff meeting
Educational handout given to
providers
Educational flyer for resource

Survey (RNs)

Pre/Post education

DNP Candidate

Interview

Late November/Early
December

DNP Candidate

Modification of
acetaminophen and ibuprofen
indication

EHR Review

December 1, 2017 –
January 29, 2018

DNP Candidate

Audit and Feedback

Automated Medication
Dispensing System

Weekly December 1, 2017
– January 29, 2018

Pharmacy technician; DNP
Candidate

Behavior Change Review

Interview

After January 29, 2018

DNP Candidate
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Measuring the Project Purpose and Objective
Purpose/Objective
• Multimodal
analgesia as
standard of care
when opioids used
• Decrease Opioidonly treatment by
50%

How measured
(tool, survey, variable
Automated Medication
Dispensing System

When Measured
Pre/PostImplementation
Intervals

Who Measured
Pharmacy
technician, DNP
Candidate
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Measuring the Clinical Question
Primary
Outcomes
Effective Pain
Relief

Opioid Use

Operational Definition

How measured
(tool, survey, variable

When Measured

Who Measured

Pain Assessment Score

EHR Review (Numerical
Pain Rating Scale; 0-10)

Pre/Post
Implementation
Intervals

DNP Candidate

Satisfaction with pain
control

Patient Experience
Report

Pre/Post
Implementation
Intervals

Press Ganey

Opioid Reliance – ratio of
opioid to non-opioid use

Automated Medication
Dispensing System

Pre/Post
Implementation
Intervals

Pharmacy
technician; DNP
Candidate

Opioid Consumption –
Morphine Equivalent Dose

Automated Medication
Dispensing System

Pre/Post
Implementation
Intervals

Pharmacy
technician; DNP
Candidate
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Results
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Evaluation of Strategies
Build a Coalition

Education
• RN staff meeting
• Educational handout
for providers
• Educational flyer for
resource
Modification of
acetaminophen and
ibuprofen order
indication

How
measured
Checklist tool
(Charge
nurses)
Interview
(Medical
director)
Pre/Post-test
(RNs)

Survey
(Providers)

When measured

Result

Every shift (Twice
daily)

Multimodal analgesia was discussed at 57.4% of
shifts (n = 58)

November 2017 –
January 2018

3 provider emails
1 meeting (December)

Pre/post education

57% (n = 19) RNs attended
Pre-test: 67% average score
Post-test: 100% average score

November 15 –
December 1

83.3% (n = 10) PAs/NPs received handout
46.6% (n = 7) physicians received handout
100% (n = 9) surveyed agreed with project
Unable to be completed
Delay on modifications due to the new EHR
Interest in changing the indication organization-wide
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Evaluation of Strategies
Intervention
Audit and feedback

Behavior Change
Review

When
measured
Automated
December 1,
medication
2017 –
dispensing system January 29,
report
2018
February,
Interview
2018
How measured

Result
Weekly opioid-only therapy was consistently 50% lower than
pre-implementation data

RN Themes:
• “Once I explained multimodal to patients, most of them
agreed.”
• “I changed my practices after learning about multimodal
analgesia”
• “Multimodal seemed to help some patients more than
others.”
Provider Themes:
• “I always prescribed a variety of pain medications”
• “I treat patients based on their clinical presentation”
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Evaluating the Project Purpose and Objective
Implement multimodal analgesia as the standard of care when opioids are used.
Aim: Decrease opioid-only pain management by 50%

Percentage of Patients Receiving Each Category of Analgesic Combination
60.00%

50.00%

56.30%

Pre-Implementation: N = 643
Post-Implementation: N = 597
44.70%

40.00%

30.00%

29.80%

29.20%

26.10%

20.00%
13.90%
10.00%

0.00%

Acetaminophen or NSAID only

p = 0.1479

Multimodal

Opioid-only

p < .0001

p < .0001
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Evaluating the Clinical Question
Pain Relief: EHR Chart Review
Demographics

Pre-Implementation
N = 62
% (n)
28 (45.16%)
17 (27.42%)

Post-Implementation
N = 58
% (n)
31 (53.45%)
8 (13.79%)

p-value

Acetaminophen or NSAID only

17 (27.42%)

19 (32.76%)

0.52

Non-Opioid was Ordered (Yes)

47 (75.81%)

51 (87.93%)

0.10

28 (60.87%)
Median [IQR]

39 (76.47%)
Median [IQR]

0.08

[Range]
15 [30]

[Range]
10 [26]

[0 – 135]
Mean ± SD

[0 – 168.5]
Mean ± SD

[Range]
51.27 ± 19.76

[Range]
58.81 ± 19.13

[18 – 99]

[18 – 93]

4.21 ± 2.27

3.00 ± 1.91

[0 – 10]

[0 – 10]

Multimodal Analgesia used
Opioid-only Analgesia used

If Ordered, Non-Opioid was Used (Yes)

MME

Age (years)
Average Pain Assessment Score

0.36
0.07

0.50

0.04
.002
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Evaluating the Clinical Question
Pain Relief: Pain Assessment Scores* lower
First 10 Pain Assessment Scores
6

5.11
5

4.63
4.3

4

3.78

3.65

4.35

4.29
4

4.1

3.92
3.64

3.6

3.25
3.03

2.85

2.82

3

2.96
2.56

2.41

2.35

2

Pre-Implementation: n = 62
Post-Implementation: n = 58

1

p = .002

0

1st

2nd

3rd

4th

5th
Pre-Implementation

6th
Post-Implementation

7th

8th

9th

10th

*Based on Numeric Pain Rating Scale of 0-10;
0 being no pain and 10 being worst pain imaginable
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Evaluating the Clinical Question
Pain Relief: Satisfaction significantly lower
Press Ganey: How well was your pain controlled?
90.00%
80.00%

81.80%

83.30%

80.60%

p = 0.003

75.80%
71.30%

70.00%

62.50%
60.00%

55.60%

54.50%
50%

50.00%
40.00%
30.00%
20.00%
10.00%
0.00%
May

June

n = 44

n = 26

July

August

September

October

November

December

January

n = 26

n = 33
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Evaluating the Clinical Question
Opioid Use: Reliance on opioids significantly less
Dispenses by Percentage
120.00%

100.00%

80.00%

24.10%
Non-Opioid

36.10%
Non-Opioid

60.00%

40.00%

75.90%
Opioid-Containing

p < .0001

63.90%
Opioid-Containing

20.00%

0.00%

Pre-Implementation: N = 2877

Post-Implementation: N = 2731
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Evaluating the Clinical Question
Opioid Use: Consumption not significantly different

Median MED

Pre-Implementation Participants
Receiving an Opioid
N = 464

Post-Implementation Participants
Receiving an Opioid
N = 404

Median [IQR]
[Range]

Median [IQR]
[Range]

p-value

20 [35]
[2 – 527.5]

20 [30]
[1 – 392]

0.6
*Mann Whitney U test
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Evaluating the Clinical Question
Opioid Use: Consumption Distribution
MED Distribution by Percentage
90

80

83.2

Pre-Implementation: N = 465
Post-Implementation: N = 404

78.7

70

60

50

40

30

20

15.1

11.6

10

3.9

2.2

4.1

3

0

0 - 50

≈ 80% of patients
received 1-50MED

51-100

101-150

>150

≈ 20% of patients received > 50MED
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Evaluating the Clinical Question
Opioid Use: Consumption among 80% Low and 20% High Utilizers
Opioid Use: Low and High Utilizers
140

p = 0.01

118.71

120

100

91.54

80

60

p = 0.21

40

19.15

20

18.37

0
Low Utilizers

Multimodal:
.0001
Opioid-only:

High Utilizers

232 (62.4%) vs

249 (77.1%)

p<

139 (37.3%) vs

74 (22.9%)

p < .0001
Pre-Implementation

Multimodal:
Opioid-only:

46 (48.4%) vs
49 (51.6%) vs

73 (88%)
10 (12%)

p < .0001
p < .0001

Post-Implementation
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Discussion
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Discussion
• Effective pain relief
• Difficult to measure subjective sensation

• Satisfaction decreased
• Studies demonstrate the more opioids used, the more reported satisfaction
(Sites et al., 2018)

• Opioid Reliance decreased
• Provider and Nursing practices

• MED decreased in high utilizers; not in non-high users
• Multimodal analgesia produces significance the more opioids are used
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Limitations
• Length of stay: Median 18 hours
• Low utilizers vs High utilizers

• Current Opioid Users
• Not consistently assessed….yet

• External Environment
• Bias by providers, RNs and/or patients?
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Implications for Practice
• Acute Nociceptive Pain
• Engaged staff is crucial
• Limiting unnecessary opioid use could decrease perpetuation of
opioid crisis in certain settings
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Conclusions
Multimodal analgesia appears to provide effective pain relief while also
reducing reliance on opioids and consumption in high utilizers but does
reduce patient satisfaction in certain settings .
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Budget
Potential cost mitigation:
$31,483.00 the first year

Initial Cost: Evidence-based Pain Management
Transitioning focus from opioids to multimodal analgesia for pain
management
Revenue
Project Manager Time (in-kind donation)
Team Member Time:
Statistician (in-kind donation)
Presidential Research Grant: White Paper for organization, educational
flyers, binder to leave on unit for next step
Cost mitigation (Prevention of 1 hospitalization and 1 ED visit related to
opioid overdose per year)
3.8-day Hospitalization (1-year period)
Emergency department visit (1-year period)

2,820.00
100.00
114.80

29,497.00
3,640.00

TOTAL INCOME
Expenses
Project Manager Time (in-kind donation)
Statistician (in-kind donation)
Color-printed Educational Flyers
Professionally Printed White Paper
Binder with steps for sustainability
Team Member Time:
Registered Nurses (extra time spent in staff meeting to be educated on
pilot project)
Educate NPs and PAs (time spent reading education on pilot project)

36,171.80

Educate Physicians (time spent reading education on pilot project)
Pharmacist Consultation (one-time cost occurrence)
Clinical Nurse Specialist Consultation (one-time cost occurrence)

655.00
60.00
96.00

Pharmacy Technician generating weekly report (8-time occurrence)
TOTAL EXPENSES

128.00
4,688.80

OPERATING INCOME

2,820.00
100.00
82.80
25.00
7.00

225.00
490.00

31,483.00
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Sustainability
• Continuing DNP project underway
• Modify analgesic indications in electronic order sets
• Organization considering modification to acetaminophen and ibuprofen “For
pain 1-10; may co-administer with an opioid for pain 4-10”

• Education for new RNs in orientation packet

______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
__

IMPLEMENTION OF EVIDENCE-BASED PAIN MANAGEMENT

154

Slide 52

Dissemination
Within Organization
• Unit Presentation
• Central Shared Leadership
Presentation
• Organization Poster Presentation
• Organization Opioid Prescribing and
Pain Management Steering Committee
• Organization Nursing Research Council

•
•
•
•
•
•

Beyond Organization
KCON CEU Event
MICNP Annual Conference
Sigma Theta Tau
Seeking Publication of Literature
Review and Manuscript
3MT® (GVSU and Regional
Competition)
Inclusion in chapter of The DNP
Scholarly Project: A Framework for
Success
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DNP Essentials

______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
__

IMPLEMENTION OF EVIDENCE-BASED PAIN MANAGEMENT

156

Slide 54

Reflection on DNP Essentials
• Essential I: Scientific Underpinnings
• Opioid-centric practices ineffective
• Multimodal analgesia approach to
pain
• Enhanced pain relief
• Decreased opioid-reliance

• Essential II: Organizational and
Systems Leadership
• Audit and feedback reports
• Facilitator of project
• Sensitive to beliefs about opioids and
pain

• Essential III: Clinical Scholarship and
Analytical Methods for EBP
•
•
•
•

Organizational Assessment
Literature Review
Evidence-based intervention
Dissemination to other units

• Essential IV: Information Technology
• AMDS (Pyxis) Reports
• EHR Chart review
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Reflection on DNP Essentials
• Essential V: Health Care Policy
• Assessed current pain management
policies
• Attended Organization Pain Steering
committee
• Submitted Order Change Proposal

• Essential VI: Interprofessional
Collaboration
• Collaborated with several disciplines
•
•
•
•

Nursing
Medical
Pharmacy
Business Executives

• Essential VII: Population Health
• Identified aggregates
• Low vs High Utilizers

• Pain relief for acute nociceptive pain
• Identified satisfaction issues

• Essential IV: Advanced Practice
Nursing
• Systematic assessment of pain
management practices
• Mentored and supported other nurses
in pain management
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Thank you!
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